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6ABSTRACT
The retractor penis muscle is a paired smooth muscle which in several non-primate mammals
belongs to the external reproductive organs together with the penis and the testes. An active
neurogenic relaxation of the retractor penis muscle constitutes a prerequisite for erection since
normally this muscle is contracted and retains the flaccid penis under the skin. The tone of the
retractor penis muscle is strictly synchronized with that of the penile artery and the smooth muscle
in the walls of the cavernous spaces. Accordingly, these smooth muscles have a very similar or an
identical innervation.
An aim of the present study was to evaluate the bovine retractor penis muscle as a tool for the
assessment of ganglion-blocking activity. The second aim was to examine the role of K+ in the
relaxation of this muscle. The third aim was to characterize some of the binding sites and the
functional effects of endothelins on the bovine retractor penis muscle and penile artery. The bovine
metatarsal artery was used as a reference because of its different innervation.
The relative ganglion-blocking activity of neuromuscular blocking and other drugs, assessed
as their capacity to inhibit the nicotine-induced relaxation of the bovine retractor penis muscle,
conformed well to the results obtained with other pharmacological methods. Therefore, this
technique can be used as an alternative, sensitive in vitro method for the quantitative assessment of
ganglion-blocking activity. For example, it may be useful for rapid exclusion of excess ganglion-
blocking activity of drug candidates.
The results showed that the relaxation of the bovine retractor penis muscle induced by a small
K+ excess is at least in part due to activation of Na+-K+ ATPase. They also suggest that in this
muscle there are neuronal K+ channels which modulate nitric oxide synthesis and/or release by
regulating Ca2+ flow into the nerve endings.
In the bovine retractor penis muscle and penile artery, the contractions induced by endothelin-
1 and endothelin-3 are mediated primarily via ETA-receptors. The activation of ETA-receptors might
constitute one of the mechanisms, which maintain the flaccid state of the penis. In the bovine
retractor penis muscle, penile artery, and metatarsal artery the ETB-receptors are predominantly
located on nerves. This suggests that the occurrence of nervous ETB-receptors is not linked to the
type of efferent nerve. The sarafotoxin S6c-induced relaxation of the bovine retractor penis muscle
is mediated by ETB-receptors located on nerves and involves the activation of the L-arginine/nitric
oxide synthase pathway. The relaxation is inconsistent, weak and tachyphylactic. The physiological
significance of the nervous ETB-receptors is not known, but on the basis of the present results these
receptors do not appear to be important regulators of the inhibitory nitrergic nerves that are
responsible for the induction of penile erection.
7ABBREVIATIONS
4-AP 4-aminopyridine
ATP adenosine triphosphate
BMA bovine dorsal metatarsal artery
BPA bovine penile artery
BRP bovine retractor penis muscle
[Ca2+]i intracellular free calcium concentration
cAMP adenosine 3',5'-cyclic monophosphate
CHO Chinese hamster ovary
DAG diacylglycerol
cDNA complementary deoxyribonucleic acid
cGMP guanosine 3',5'-cyclic monophosphate
CNS central nervous system
ECE endothelin converting enzyme
EDRF endothelium-derived relaxing factor
EFS electrical field stimulation
ET-1 endothelin-1
ET-2 endothelin-2
ET-3 endothelin-3
GTP guanosine triphosphate
5-HT 5-hydroxytryptamine
IF inhibitory factor extracted from the BRP
IP3 inositoltriphosphate
L-NAME NG-nitro-L-arginine methyl ester
L-NMMA NG-monomethyl-L-arginine
L-NNA NG-nitro-L-arginine
MAP mitogen activated protein kinase
mRNA messenger ribonucleic acid
NADPH nicotinamide adenine dinucleotide phosphate (reduced form)
NANC non-adrenergic non-cholinergic
NO nitric oxide
NOS nitric oxide synthase
PI phosphoinositol
PKC protein kinase C
PLC phospholipase C
PNS peripheral nervous system
S6c sarafotoxin S6c
TEA tetraethylammonium
VIC vasoactive intestinal constrictor
VIP vasoactive intestinal peptide
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91. INTRODUCTION
In male mammals the external reproductive organs include the penis and the testes. In
addition, in many mammalian species, these organs also comprise a paired smooth muscle,
i.e. the retractor penis muscle, which has an important protective function by retaining the
flaccid penis under the skin. The retractor penis does not exist in primates or lagomorphs,
but it is especially well developed in the artiodactyls and has also great importance in most
perissodactyls, canidae, felidae and certain rodents. The distribution of smooth muscle in
the external reproductive organs also differs between species in other ways. For example, in
the artiodactyls, the corpora cavernosa have a fibrous structure and are, contrary to the
corpora cavernosa of most other mammals, almost devoid of smooth muscle and autonomic
nerves (Klinge and Sjöstrand 1977a).
Simultaneous relaxation of smooth muscles in the arteries supplying the cavernous bodies,
in the walls of the cavernous spaces and in the retractor penis, constitutes a prerequisite for
the initiation of penile erection. When these muscles relax, the cavernous tissue becomes
engorged and the penis protrudes, and when they contract, the penis returns to its flaccid
state. Because of this timely co-ordinated function, these smooth muscles can be regarded as
a functional entity and called the smooth muscle effectors of penile erection (Klinge and
Sjöstrand 1977a).
Despite the considerable dissimilarities in the angioarchitecture of the penises of various
species, the innervation of penile smooth muscle as well as the neurotransmission
mechanisms involved seem to have undergone clearly smaller changes in the course of the
evolution. Functional studies suggest that there are few major differences between the
receptors for the classical neurotransmitters. The excitatory innervation of the smooth
muscle effectors of penile erection is adrenergic in all mammals, and the neuroeffector
junction is characterized by high efficiency. The nature and function of cholinergic nerves
is, however, less well understood. But with respect to the prejunctional muscarinic
suppression of excitatory adrenergic neurotransmission, in vitro studies reveal great
similarity between several species (Klinge and Sjöstrand 1977b; Hedlund et al. 1984; Saenz
de Tejada et al. 1989). Transmission of impulses from the non-adrenergic non-cholinergic
(NANC) inhibitory nerves seems to be rather similar or even identical in different species.
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Experiments performed with inhibitors of nitric oxide synthase (NOS) have revealed that at
the neurochemical level, the inhibitory nerves function similarly in all species studied (see
Klinge and Sjöstrand 1994; Andersson and Wagner 1995).
Direct neurogenic relaxation of smooth muscles is an event which is of great functional
importance only in certain arteries or other organ systems. This is especially the case with
the above-mentioned smooth muscle effectors of penile erection. Indeed, macroscopically
penile erection may be the most impressive phenomenon based on active neurogenic
relaxation. Comparable smooth muscles are to be found also in the cerebral arteries (Toda
1995) and the gastrointestinal tract (Rand and Li 1995). Specimens of the deep and dorsal
penile arteries, the corpus cavernosum and the corpus spongiosum have been used in studies
aimed at the characterization of the inhibitory neutrotransmission to penile smooth muscle
and the effects of drugs on erectile tissue (see Klinge and Sjöstrand 1994; Andersson and
Wagner 1995). Since the innervation of the retractor penis is dense and very similar to or
identical with that of the other smooth muscle effectors of penile erection (Klinge and
Sjöstrand 1974; 1977a), this paired smooth muscle constitutes an interesting model that has
been widely used for the characterization of the peripheral neuronal mechanisms serving
erection. This is especially true for the bovine retractor penis muscle (BRP), since it is large
and readily accessible, and normally belongs to the waste material of abattoirs.
The goal of the present study was to investigate the usefulness of the nicotine-induced
relaxation of the BRP in the assessment of ganglion-blocking activity of drugs, and to
examine the role of K+ in the relaxation of this muscle. Furthermore, the effects and possible
binding sites of endothelins were studied. The background for the endothelin studies lies in
the fact that since the discovery of these peptides (Yanagisawa et al. 1988b), much work has
been carried out to characterize their role in the modulation of the tone of penile smooth
muscles. The ability of endothelin-1 (ET-1) to induce contraction, and the presence of ET-1
binding sites, as well as the synthesis and release of ET-1 by erectile tissues, have suggested
that endothelins may at least in some mammalian species play a role in the maintenance of
the flaccid state of the penis (Holmquist et al. 1990a; Saenz de Tejada et al. 1991).
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2. REVIEW OF THE LITERATURE
2.1. Anatomy and innervation of the bovine retractor penis muscle
The bovine retractor penis muscle (BRP; Fig. 2.1.) is a large paired smooth muscle. After a
broad insertion to the bone the muscle forms tight bundles which pass the anal orifice.
Distal to the anus, the right and left bundle run close to each other but in separate connective
tissue sheaths on the surface of the bulbocavernosus muscle and proceed from the root of
the penis directly to the second, caudally convex curve of the sigmoid flexure. Here they are
attached to the lateral surfaces of the penis by a broad and flat fascial band (Heinemann
1937; Habel 1975).
Figure 2.1. Schematic drawing of the gross anatomy of the bovine retractor penis muscle.
Posterolateral view after removal of the tail, the skin, the testes and the right hind limb. 1. Insertion
of the right retractor penis to the ventral surface of the upper coccygeal vertebrae and caudal part of
the sacrum. 2. Anal orifice. 3. Left thigh. 4. Bulbocavernosus (also called bulbospongiosus) muscle.
5. Ischiocavernosus muscle. 6. Characteristic sigmoid flexure of the flaccid penis. 7. Right retractor
penis just proximal to its lateral insertion to the distal part of the penis. 8. Prepuce of the glans
penis.
The tone of the retractor penis and the other smooth muscle effectors of penile erection is
strictly synchronized and, accordingly, these muscles have a similar or an identical
innervation. Their excitatory adrenergic supply comes from the sympathetic paravertebral
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chains and reaches the muscles along the pudendal, hypogastric and pelvic nerves (De Groat
and Booth 1993). Although there are species variations in the relative importance of these
pathways, in all mammals studied the dominant pathway is constituted by the pudendal
(pudic) nerve (Dail 1993; Sjöstrand et al. 1993; Klinge and Sjöstrand 1994). The relaxation
of the smooth muscle effectors of penile erection is mediated mainly via the
parasympathetic pelvic nerves, originating usually at the level of the second to fourth sacral
segments (S2-S4), and to a varying extent also via the sympathetic hypogastric nerves
(Sjöstrand and Klinge 1979; Dail et al. 1986; Sjöstrand et al. 1993). Both of these
preganglionic nerve sets have their ganglionic relay in the pelvic plexus from which the
postganglionic neurons emanate. The activation of the erection-inducing nerves is regulated
by the integrating centers in the lumbar and sacral segments of the spinal cord. Both centers
can be activated by central psychogenic stimuli via efferent pathways (psychogenic
erection) while the sacral center can also be activated via afferent nerves due to local
stimulation of the genital organs (reflexogenic erection) (De Groat and Steers 1988). These
afferent nerves run predominantly along the pudendal nerve and mainly synapse in the
sacral dorsal root ganglia (Kumazava 1986).
In the nerves innervating the BRP and the bovine penile artery (BPA), electron microscopy
has revealed four different types of synaptic vesicles (Eränkö et al. 1976; Klinge et al.
1978). There are small dense-core vesicles, which are generally accepted to contain
noradrenaline, and small empty vesicles, believed to contain acetylcholine, and large opaque
and large granular vesicles, the transmitter content of which is at least in part attributable to
neuropeptides (Kandel et al. 1991). In the retractor penis of bull and boar, there are
numerous nerve fibers showing immunofluorescence for vasoactive intestinal peptide (VIP),
substance P and enkephalins (Panula et al. 1991; Majewski et al. 1999). The penile afferents
are also immunoreactive to antibodies against various neuropeptides (De Groat 1987).
Morphological evidence indicates that in the proximal part of the corpus cavernosum of
man and rat there are sparsely scattered nerve cell bodies (Gu et al. 1983; Dail et al. 1990;
Vanhatalo et al. 1996). The situation is the same in the BRP and the BPA (Alaranta et al.
1989) and in the retractor penis of the goat (Sjöstrand et al. 1993).
13
2.2. Neurogenic relaxation of the retractor penis muscle
2.2.1. Electrical stimulation of the inhibitory nerves
The initiation of erection involves simultaneous active neurogenic relaxation of the retractor
penis and the other smooth muscle effectors of penile erection. In vivo this has been
demonstrated by electrical stimulation of the parasympathetic pelvic nerves or the
hypogastric nerves of anaesthetized animals (Sjöstrand and Klinge 1979; Sjöstrand et al.
1993). In vitro strips of the retractor penis exhibiting sufficient tone can be relaxed by
electrical field stimulation (EFS; Fig. 2.2.) (Klinge and Sjöstrand 1974; 1977a). In vitro, the
relaxation is rapid and transient, but it starts several seconds after the arrival of the pulse
train. Since EFS activates the excitatory nerves as well, the relaxation at low tone of the
muscle is consistently preceded by contraction, which can be abolished by drugs inhibiting
the adrenergic neuronal function such as guanethidine or bretylium. All neurogenic
responses to EFS are inhibited by drugs which can block axonal conduction such as
tetrodotoxin and lidocaine (Klinge and Sjöstrand 1974).
Electrophysiological studies have revealed that in the smooth muscle cells of the BRP, EFS
induces both excitatory and inhibitory junction potentials (Samuelson et al. 1983; Byrne and
Muir 1984; 1985). The excitatory potentials are abolished by guanethidine and an a-
adrenoceptor antagonist phentolamine. The inhibitory potentials seem to be related to
NANC nerve stimulation, but it is possible that nerve-mediated relaxation may also occur
without an inhibitory junction potential (Samuelson et al. 1983).
2.2.2. Stimulation of the inhibitory nerves by nicotinic agonists
Both in vitro and in vivo, the response of the retractor penis of several species to
appropriate, i.e. suitably low doses of nicotine, is usually relaxation (Goldenberg 1965;
Klinge and Sjöstrand 1974; Samuelson et al. 1983), but occasionally relaxations preceded
by small contractions have been observed (Luduena and Grigas 1966; Klinge and Sjöstrand
1974; 1977a). The contraction is mainly due to noradrenaline release from sympathetic
nerve endings since it can be blocked by phentolamine (Klinge and Sjöstrand 1974).
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The nicotine-induced relaxation of the BRP is dose-dependent and resembles in several
respects the relaxation induced by EFS (Fig. 2.2.). In the dose range 10-45 µM, the nicotine-
induced relaxations are totally prevented by ganglion-blocking agents, local anaesthetics
and hypoxia (Klinge and Sjöstrand 1974; 1977a; Klinge et al. 1988). In addition, b-
adrenergic-blocking drugs have been shown to inhibit the nicotine-induced relaxation. This
effect correlates with their lipophilicity and both stereoisomers of propranolol exhibit the
same potency suggesting that the inhibition is due to the local anaesthetic activity of these
compounds (Klinge et al. 1992). Tetrodotoxin almost totally blocks the relaxation at
nicotine concentrations lower than 45 µM (Klinge et al. 1988). If too high concentrations of
nicotine or other nicotinic agonists are used, the relaxations lose their susceptibility to the
above-mentioned blocking factors. The nicotine-induced relaxation, as well as the relaxation
induced by EFS or an extract prepared from the BRP, is usually, although not invariably,
accompanied by a small membrane hyperpolarization (Samuelson et al. 1983; Byrne and
Muir 1985). It has still to be demonstrated where nicotine or other nicotinic agonists are
acting, though it seems to be primarily at the cell bodies of the inhibitory nerves. This seems
probable if one is considering where low concentrations of nicotine are acting, but higher
concentrations may well activate also the nerve endings (Klinge et al. 1988; Alaranta et al.
1989).
Figure 2.2. Nicotine (Nic)-induced rapid relaxation of a bovine retractor penis muscle strip
precontracted with 5-hydroxytryptamine (5-HT). Contractions and relaxations elicited by electrical
field stimulation (EFS) are also shown. Stimulation parameters: 40 V, 1 ms, 4 Hz for 10 s at 4 min
intervals. W = wash.
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2.2.3. Transmitters involved in the neurogenic relaxation of the bovine retractor penis
muscle
Possible cholinergic mechanisms
The mechanism of relaxation of the smooth muscle effectors of penile erection has been
studied intensely during the last decades. The involvement of acetylcholine in the induction
of erection is supported by the fact that considerable amounts of acetylcholine have been
found in the retractor penis of the dog, horse, swine, bull and ram (Klinge and Sjöstrand
1977b) and goat (Sjöstrand et al. 1993) and also in the BPA (Klinge et al. 1978).
Acetylcholinesterase-positive nerve fibers have been demonstrated in the retractor penis of
the dog (Bell and McLean 1970), bull (Klinge et al. 1970) and goat (Sjöstrand et al. 1993)
and in the BPA (Klinge and Pohto 1971). Further, electron microscopic studies have
revealed small empty presumably cholinergic vesicles in axon profiles of the BRP (Eränkö
et al. 1976) and the BPA (Klinge et al. 1978).
Cholinergic activity has been suggested to contribute to the induction and/or maintenance of
penile erection by at least three mechanisms: 1) stimulation of prejunctional muscarinic
receptors on adrenergic nerve terminals inhibits the release of noradrenaline, 2) muscarinic
receptor-mediated release of relaxant factors from the endothelium can counteract the
postjunctional effects of noradrenaline and 3) nicotinic receptor-mediated neuronal release
of relaxant factors, e.g. nitric oxide (NO), and possibly also vasodilator peptides, can
counteract the postjunctional effects of noradrenaline (see Klinge and Sjöstrand 1994;
Andersson and Wagner 1995).
The first of the above mechanisms, i.e. suppression of excitatory adrenergic
neurotransmission, is supported by electron microscopic studies showing that adrenergic
and apparently cholinergic fibers run in close juxtaposition to each other in the BRP and
BPA (Eränkö et al. 1976; Klinge et al. 1978). In addition, pharmacological evidence has
shown that in the retractor penis of dog, cat, horse, boar, bull, elk, ram and goat, the
contractions elicited by EFS of the adrenergic nerves are suppressed by acetylcholine or
physostigmine, and these suppressions are abolished by scopolamine (Klinge and Sjöstrand
1977b; Sjöstrand et al. 1993). The most convincing evidence for the existence of an intrinsic
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muscarinic mechanism, suppressing adrenergic neurotransmission is provided by the
observation that in the retractor penis of stallion and dog, these contractions are enhanced
by scopolamine. Additionally, in the canine retractor penis, the EFS evoked release of 3H-
noradrenaline is inhibited by physostigmine and enhanced by scopolamine (Klinge and
Sjöstrand 1977b). In the bovine and dog retractor penis, the excitatory junction potentials
elicited by EFS of adrenergic nerves are attenuated by physostigmine, and this effect is
blocked by scopolamine or atropine (Samuelson et al. 1983; Byrne and Muir 1984;
Kinekawa et al. 1984). Low concentrations of scopolamine or atropine enhance these
potentials in the BRP (Samuelson et al. 1983; Byrne and Muir 1984). Finally, in vivo the
contraction of the goat retractor penis induced by the stimulation of the sympathetic chains
is counteracted by simultaneous stimulation of the partially cholinergic hypogastric nerves
(Sjöstrand et al. 1993).
In several species exogenous muscarinic agonists have been shown to cause relaxation of
smooth muscle effectors of penile erection other than the retractor penis (see Klinge and
Sjöstrand 1994; Andersson and Wagner 1995). The relaxations are endothelium-mediated
via the synthesis and release of NO or other endothelium-derived relaxing factors. The
physiological role of such relaxations, however, is unclear because the origin of the
acetylcholine needed to activate the endothelial receptors is unknown. This phenomenon,
which requires an intact vascular endothelium (Saenz de Tejada et al. 1988), has not been
observed in the BRP. This could be due to the small amount of endothelial muscarinic
receptors in the vessels supplying this muscle. There are only contraction-mediating
muscarinic receptors present on the smooth muscle cells of the BRP (Klinge and Sjöstrand
1974). Taken together, the above data suggest that in the initiation and maintenance of
penile erection the cholinergic muscarinic mechanisms seem only to play a contributory role
rather than being crucially important. This is supported by the fact that clinical doses of
atropine are not known to cause impotence in man (see Klinge and Sjöstrand 1994).
The third mechanism is discussed in the section 2.2.2. dealing with the relaxation induced
by nicotinic activation of the inhibitory nerves.
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Nitric oxide and vasoactive intestinal peptide
The first results to suggest the existence of a NANC inhibitory innervation and an unknown
inhibitory neurotransmitter in the BRP showed that the relaxation elicited by EFS of the
inhibitory nerves was resistant to all autonomic blocking drugs (Klinge and Sjöstrand 1974).
Attempts were made to isolate this transmitter, and acid activation was found to constitute a
prerequisite for the pharmacological activity of an extract, the active principle of which was
named the inhibitory factor (IF) (Ambache et al. 1975; Gillespie and Martin 1980). In the
BRP, the IF yielded relaxations that were abolished by haemoglobin (Bowman et al. 1981;
1982). The IF activated guanylate cyclase and used cGMP as a second messenger (Bowman
and Drummond 1984). All of these effects were similar to those elicited by stimulation of
the inhibitory nerves. However, hypoxia did not affect the relaxant effect of the IF, whereas
it effectively but reversibly blocked the neurogenic relaxation, suggesting a prejunctional
site for the high demand of oxygen (Bowman and McGrath 1985). The discovery of the
endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadski 1980), its
characterization as NO or a NO releasing compound (Ignarro et al. 1987; Palmer et al.
1987) as well as studies of its effects, which resembled those of the IF, led to the suggestion
that the IF was NO (Martin et al. 1988).
Electrophysiological studies have revealed that the changes in membrane potential do not
fully correlate with the relaxations of BRP induced by IF or EFS (Byrne and Muir 1984;
1985). It has been suggested that in the BRP, K+ is not the principal ion mediating the
inhibitory potential to NANC nerve stimulation and to IF, and that more than one ionic
species may be involved (Byrne and Muir 1985).
In the nerves of the bovine and rat retractor penis, the presence of NOS, which
stoichiometrically synthesizes NO and L-citrulline from L-arginine (Fig. 2.3.), has been
demonstrated by immunohistochemistry and/or NADPH diaphorase staining (Sheng et al.
1992; Dail et al. 1993). The NOS found in the BRP is located exclusively within nerve
fibers (Sheng et al. 1992). The enzymatic activity of the NOS purified from the rabbit
corpus cavernosum is, as is the case in rat cerebellum, dependent on NADPH, calmodulin,
Ca2+ and tetrahydrobiopterin (Bush et al. 1992). The same cofactors are required by the
NOS isolated from the BRP (Sheng et al. 1992).
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NOS
L-arginine NO   +   L-citrulline
O2
guanylate cyclase
GTP cGMP
relaxation of smooth muscle
Figure 2.3. Synthesis of nitric oxide and its second messenger cyclic GMP.
Since L-arginine, but not D-arginine, is a physiological precursor of NO (Palmer et al.
1988), certain stereoselective analogues of L-arginine, such as NG-nitro-L-arginine methyl
ester (L-NAME) and NG-nitro-L-arginine (L-NNA) can be used as competitive inhibitors of
the NOS. In the BRP and BPA, L-NNA has been shown to block the neurogenic relaxation
elicited by EFS as well as that induced by nicotinic agonists, the IC50 value being about 2.3
µM in both tissues (Kostiainen et al. 1991; Liu et al. 1991). In the anaesthetized rat,
intravenously administered L-NAME abolished penile erection induced by the electrical
stimulation of the cavernous nerves (Burnett et al. 1992).
In addition to NO, several neuropeptides and other compounds have been suggested to be
involved in the regulation of the tone of the smooth muscle effectors of penile erection. VIP,
calcitonin-gene related peptide, prostaglandin E1 , prostaglandin E2 and prostaglandin I2 are
the most extensively studied (see Klinge and Sjöstrand 1994; Andersson and Wagner 1995).
VIP is the only peptide for which the role of an inhibitory neurotransmitter has been
proposed. However, it seems that the role of these compounds in the relaxation of the
above-mentioned smooth muscles is only contributory and of lesser importance than that of
NO. Interestingly, in the rat corpus cavernosum, but not in the BRP or the BPA, VIP-
immunoreactivity has been shown to coincide with neuronal NOS-immunoreactive nerves
and with vesicular acetylcholine transporter protein immunoreactive nerves (Hedlund et al.
1999; Vanhatalo et al. 2000). VIP has been shown to colocalize with neuronal NOS also in
the corpus cavernosum of man (Ehmke et al. 1995; Tamura et al. 1995).
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2.3. Effects of K+ on penile smooth muscle
In electrically excitable tissues, including vascular and other smooth muscle, K+ channels
importantly contribute to the regulation of the membrane potential. Opening of K+ channels
leads to a flow of K+ ions out of the smooth muscle cell, membrane hyperpolarization,
closure of voltage-gated Ca2+ channels and smooth muscle relaxation. Closure of K+
channels has the opposite effect. Since the penile artery and the trabecular smooth muscle
contain several types of K+ channels (Table 2.1.), it is obvious that drugs modulating K+
currents may affect the contractile state of penile smooth muscle (Fig. 2.4.).
Figure 2.4. Principal potassium channels affecting the tone of smooth muscle. ADP = adenosine 5'-
diphosphate, ATP = adenosine 5'-triphosphate, [Ca2+]i = intracellular free calcium concentration,
KATP = ATP-sensitive K
+ channel, KCa = Ca
2+-activated K+ channel, KIR = inward rectifier K
+
channel, KV = voltage-dependent K
+ channel, 4-AP = 4-aminopyridine, TEA =
tetraethylammonium, + = opening, - = blockade, ­ = increase, ¯ = decrease (modified from
Jackson 2000, with permission).
ATPase
K+
ADP ­  +
ATP ­   -KATP
KCa
[Ca2+]i  ­   +
membrane potential ­   +
2K+
3Na+
membrane potential ­   +
KV
KIR
Barium -
K+
4-AP   -
K+
K+
Apamin  -
Charybdotoxin  -
TEA  -
NS 1619  +
Cromakalim  +
Pinacidil     +
Glibenclamide -
Tolbutamide  -
Ouabain   -
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Table 2.1. Potassium channels identified in penile tissues.
Channel
type
Tissue Reference
KATP Cultured human corporal smooth muscle Lee et al. 1999
Porcine and simian corpus cavernosum
Human corpus cavernosum
Rabbit corpus cavernosum
Feline corpus cavernosum
Human deep cavernous artery
Giraldi and Wagner 1990
Giraldi and Wagner 1990;
Holmquist et al. 1990c
Holmquist et al. 1990b
Hellström et al. 1992
Hedlund et al. 1994
BKCa Horse deep penile artery
Cultured human and rat corporal smooth
muscle
Simonsen et al. 1995
Wang et al. 2000
KV Cultured human corporal smooth muscle Christ et al. 1993b
KA Cultured human corporal smooth muscle Christ et al. 1993a
KATP = ATP-sensitive K
+ channel, BKCa = large conductance Ca
2+-activated K+ channel, KV =
voltage-dependent delayed rectifier K+ channel, KA = voltage-dependent A-type K
+ channel
K+ channel openers such as pinacidil, nicorandil, and cromakalim relax various types of
smooth muscle cells by opening ATP-sensitive K+ channels. The opening leads to
hyperpolarization of the cell membrane, which decreases the open-state probability of
voltage-dependent Ca2+ channels (e.g. Thesleff 1980). In isolated human corpus
cavernosum, pinacidil abolished spontaneous contractile activity, effectively relaxed
preparations contracted by noradrenaline, and inhibited contractions induced by EFS.
Pinacidil also depressed contractions induced by relatively low (£ 20 mM) concentrations of
K+, and concentration-dependently increased the efflux of 86Rb+ from preloaded tissue
(Holmquist et al. 1990c). In isolated corpus cavernosum from rabbit, cromakalim was three
to four times more potent than pinacidil (Holmquist et al. 1990b). Pinacidil at high
concentrations relaxed pig corpus cavernosum (Giraldi and Wagner 1990). This effect was
considered not to be related to pinacidil’s K+ channel opening action. Nicorandil, which in
addition to being a K+ channel opener also acts as a donor of NO, produced concentration-
dependent relaxation of the human corpus cavernosum and the deep cavernous artery which
had been contracted by noradrenaline or ET-1 (Hedlund et al. 1994). Glibenclamide, a
blocker of ATP-sensitive K+ channels, inhibited nicorandil-induced relaxation in corporal
tissue, but not in arterial preparations. In anaesthetized monkeys intracavernous injection of
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pinacidil produced tumescence or erection similarly to that attained with papaverine (Giraldi
and Wagner 1990). In cats, lemakalim, nicorandil, and pinacidil, all caused erections in a
dose-dependent manner when injected intracavernosally, which supports the view that in
corporal smooth muscle opening of K+ channels is of functional importance (Hellström et
al. 1992). In the BRP, apamin had no effect on relaxations induced by EFS or the IF
(Bowman and Gillespie 1981; Byrne and Muir 1984).
In conclusion, among the variety of K+ channels present in smooth muscle cells, the ATP-
and Ca2+-sensitive K+ channels seem to be the most prominent in penile tissues and thus
they are likely to contribute to the modulation of penile smooth muscle tone.
2.4. Endothelins
2.4.1. Structure and biosynthesis
Endothelin-1 (ET-1) is a potent vasoconstrictor peptide which was originally isolated from
the medium of cultured porcine aortic endothelial cells (Yanagisawa et al. 1988b). ET-1 and
its isopeptides, endothelin-2 (ET-2) and endothelin-3 (ET-3), comprise 21 amino acid
residues including four cysteine residues which form two disulfide bonds (Fig. 2.5.). The
three peptides are encoded by separate genes and constitute a family named the endothelins
(ETs) (Inoue et al. 1989). The vasoactive intestinal constrictor (VIC) and the sarafotoxins
also belong to this family. VIC was identified by cloning cDNA from mouse intestine, and
it has a high homology with ET-2 (Saida et al. 1989). The sarafotoxins are structurally
similar peptides isolated from the venom of the Israeli burrowing asp Atractaspis
engaddensis (Takasaki et al. 1988).
The ETs are initially synthesized in the form of precursors known as preproendothelins
which comprise about 200 amino acid residues, depending on the isopeptide and the
species. These large molecules undergo a proteolytic cleavage by endopeptidases to form
the 38-41 amino acid precursors named proendothelins or big endothelins (big ETs). Big
ETs are further processed by the action of the endothelin converting enzymes (ECE) to form
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the active 21 amino acid peptide (Fig. 2.6.). This step involves the cleavage of a tryptophan-
valine bond in the case of ET-1 and ET-2, and a tryptophan-isoleucin bond in the case of
ET-3. ECEs are membrane-bound metalloproteases which are inhibited by phosphoramidon
and exist in several isoforms (see Turner and Murphy 1996; Russell and Davenport 1999).
A)
B)
Figure 2.5. Primary structures of the endothelins, the vasoactive intestinal constrictor (VIC), and
the sarafotoxins. A) The nine conserved amino acid residues in the peptides and the positions of the
disulphide bridges. B) The full sequence of endothelin-1 (ET-1) and the substitutions relative to this
peptide found in the other members of the endothelin family (modified from Hiley 1995, with
permission).
ET-1 is the only family member produced in endothelial cells, but it is also expressed in
vascular smooth muscle and non-vascular tissues, such as the brain, kidney and lung
(Sakurai et al. 1991). ET-2 and ET-3 can be detected in the kidney and intestine (Ohkubo et
al. 1990; Bloch et al. 1991; Shiba et al. 1992). ET-1 and ET-3 are relatively abundant in
neuronal tissue (see Kuwaki et al. 1997).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
ET-1 Cys Ser Cys Ser Ser Leu Met Asp Lys Glu Cys Val Tyr Phe Cys His Leu Asp Ile Ile Trp
ET-2 Trp Leu
ET-3 Thr Phe Thr Tyr Lys Tyr
VIC Asn Trp Leu
S6a Lys Asp Met Thr Leu Asn Gln Val
S6b Lys Asp Met Thr Leu Gln Val
S6c Thr Asn Asp Trp Leu Glu Leu Asn Gln Val
S6e Thr Lys Asp Met Thr Leu Gln Gly
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Figure 2.6. Proteolytic cleavage of human endothelin-1 from its prepro-form (modified from Goto
et al. 1996, with permission).
2.4.2. Characterization of endothelin receptors by functional and binding assays and by
molecular cloning
According to the pharmacological potency order of the three ET isopeptides observed in a
variety of tissues, organs or organ systems, the mammalian endothelin receptors can be
classified into two groups (Table 2.2.). In general, with respect to the first group of
responses, which include vasoconstriction in most arteries and bronchoconstriction in
certain species, ET-1 and ET-2 are more potent than ET-3. In the second group, which
include vasodilation, and bronchoconstriction in certain species, the three isopeptides have a
similar potency. The receptors involved in mediating the first set of responses are named
ETA- and in the second set they are called ETB-receptors. Furthermore, ETB-receptors
located on the endothelium and mediating relaxation of vascular smooth muscle, and on
smooth muscle cells mediating contraction, have been named ETB1- and ETB2-receptors,
respectively (Sokolovsky et al. 1992). In the following the ETB1- and ETB2-receptor
terminology will be used where it seems appropriate, even though it is most likely that it
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only reflects the location of receptor and type of effect, but not the existence of two different
receptor proteins (Mizuguchi et al. 1997). Furthermore, currently no ligand has been
developed which is clearly selective for the ETB1- or ETB2-receptors. The ETB1 /ETB2-
receptor classification is as yet not applicable to ETB-receptors shown to exist in nervous
structures.
Table 2.2. Principal classification of responses to ET-1 and ET-3 in various mammalian tissues
based on the order of potency and/or receptor affinity of these peptides.
Type I responses (ET-1 > ET-3)
Tissue or organ (species) Assay Reference
Vascular smooth cells
(rat, pig)
Bronchial smooth muscle
(sheep)
Smooth muscle of urinary
bladder (human)
Smooth muscle of ileum
(guinea-pig)
Pressor effect in vivo, contraction,
PI generation, binding assay
Contraction
Contraction
Contraction
Inoue et al. 1989
Goldie et al. 1994
Maggi et al. 1990
Miasiro et al. 1995
Type II responses (ET-1 = ET-3)
Whole animal (rat)
Mesenteric artery (rat)
Saphenous vein (rabbit)
Tracheal or bronchial smooth
muscle (human, rat, mouse,
guinea-pig)
Smooth muscle of ileum
(guinea-pig)
Mesangial cells (rat)
Astrocytes (rat)
Initial depressor response in vivo
Transient relaxation, EDRF release
Contraction
Contraction
Relaxation followed by contraction
PI generation, binding assay
PI generation, Ca2+ transient
Inoue et al. 1989
Warner et al. 1989
Moreland et al. 1992
Hay 1992; Henry 1993;
Henry and Goldie 1994;
Goldie et al. 1995
Miasiro et al. 1995
Martin et al. 1990
Marsault et al. 1990
In radioligand binding studies, the order of affinity of ETs for membrane fractions from
various tissues, such as rat aorta (Jones et al. 1991), mesangial cells (Sugiura et al. 1989;
Martin et al. 1990) and lung (Masuda et al. 1989), and rabbit urinary tract (Latifpour et al.
1995) has also demonstrated that there are at least two distinct types of ET receptors. In
addition, based on pharmacological and radioligand binding experiments, the existence of a
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receptor specific for ET-3 has been suggested in cultured bovine endothelial cells (Emori et
al. 1990) and rat anterior pituitary cells (Samson et al. 1990). Subsequently,
pharmacological evidence has accumulated suggesting that there might exist further types or
subtypes of ET receptors (Warner et al. 1993a; Hori et al. 1994; Sudjarwo et al. 1994;
Yoneyama et al. 1995a). However, the dissimilarity of the above-mentioned ETB1- and
ETB2-receptors has been questioned. It has also been suggested that the inability of some
ETB-receptor antagonists to inhibit the ET-1-induced ETB2-receptor mediated contraction is
due to cross-talk between receptors that allows ETA-receptors to compensate for blockade of
ETB2-receptors (Clozel and Gray 1995).
So far, only two classes of cDNA clones encoding the ET receptors have been isolated from
mammalian tissues (Arai et al. 1990; Sakurai et al. 1990; Hosoda et al. 1991; Lin et al.
1991; Nakamuta et al. 1991; Ogawa et al. 1991; Saito et al. 1991; Sakamoto et al. 1991).
The structures of the mature ET-receptors have been deduced from the nucleotide sequences
of the cDNAs. The encoded proteins contain seven transmembrane stretches of 20 to 27
hydrophobic amino acid residues in both ET receptor types, revealing a G-protein-coupled
receptor that belongs to the rhodopsin-type subfamily. The two encoded mammalian
receptors consist of approximately the same number of amino acid residues, ranging from
415 to 452 (Table 2.3.). According to the relative binding affinities of the three ET-
isopeptides for the cloned receptors expressed in transfected mammalian cells, the receptors
can be classified into two groups consistent with the results of the pharmacological
experiments. The order of affinity for the ETA-receptor is ET-1 ³ ET-2 >> ET-3 whereas for
the ETB-receptor all the three ETs have equal affinity. The human or bovine ETA- and ETB-
receptors have about 63 % amino acid homology. The human ETB-receptor shows a high
homology (85 %) to the rat and bovine ETB-receptor (Sakamoto et al. 1991; Sakurai et al.
1992). In addition, a receptor has been cloned from the dermal melanophores of Xenopus
laevis that shows functional selectivity for ET-3 over ET-1. It was named the ETC-receptor
(Karne et al. 1993). Its amino acid sequence shows homologies of 47 % and 52 % with
mammalian ETA- and ETB-receptors, respectively. Whether this receptor represents a
species variant of ETA- or ETB-receptor, or is a subtype with a distinct, as yet
undemonstrated mammalian homologue, is so far not clear.
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Table 2.3. Molecular cloning of ET-receptor types
                                                                                                                                                            
Number of
cDNA library amino acids Reference
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
ETA-receptor
Bovine lung 427 Arai et al. 1990
Human lung 427 Haendler et al. 1992
Rat A10 vascular 426 Lin et al. 1991
  smooth muscle cells
Human heart 427 Elshourbagy et al. 1993
Human placenta 427 Adachi et al. 1991; Hayzer et al. 1992
Human placenta 421 Cyr et al. 1991
Xenopus laevis heart 415 Kumar et al. 1994
ETB-receptor
Rat lung 415 Sakurai et al. 1990
Human lung 442 Haendler et al. 1992; Elshourbagy et al. 1993
Human liver 442 Nakamuta et al. 1991
Human placenta 442 Ogawa et al. 1991
Human placenta 452 Shyamala et al. 1994
Human placenta 436 Elshourbagy et al. 1996
Human jejunum 416 Sakamoto et al. 1991
Human prostate 442 Webb et al. 1995
Rat brain 442 Cheng et al. 1993
Porcine cerebellum 443 Elshourbagy et al. 1992
Avian embryo 347 Nataf et al. 1996
Avian melanocytes 436 Lecoin et al. 1998
ETC-receptor
Xenopus laevis 444 Karne et al. 1993
  dermal melanophores
                                                                                                                                                             
Northern blot analyses and in situ hybridisation studies have shown that ET receptor mRNA
is expressed in a number of rat tissues including the brain, lung, heart and kidney
(Davenport et al. 1989; Sakurai et al. 1990; Lin et al. 1991; Hori et al. 1992).
Autoradiographic studies have shown that ET receptors exist in human (McKay et al. 1991;
Knott et al. 1995), sheep (Goldie et al. 1994), guinea-pig (Tschirhart et al. 1991), and rat
(Henry 1993) airway smooth muscle, and in several cardiovascular tissues including human
pulmonary arteries (McKay et al. 1991), renal vasculature (Davenport et al. 1994; Maguire
et al. 1994) and coronary arteries (Chester et al. 1989; Power et al. 1989; Dashwood et al.
1994; Russell et al. 1997), porcine coronary arteries (Power et al. 1989) and pulmonary
vessels (Kobayashi et al. 1993), rat aorta (Jones et al. 1991), rabbit aorta and carotid artery
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(Dashwood et al. 1989), as well as porcine (Davenport et al. 1989; Yamasaki et al. 1989)
and human heart (Davenport et al. 1989).
In the urogenital area, ET receptors have been demonstrated in rabbit lower urinary tract
(Garcia-Pascual et al. 1990) and penile cavernosal tissue (Sullivan et al. 1997; 1998), rabbit
and human deep penile arteries and human circumflex veins (Holmquist et al. 1992a), rat
corpus cavernosum (Bell et al. 1995) and prostate (Auger-Pourmarin et al. 1998) and human
prostate (Kobayashi et al. 1994b). In neuronal structures, ET receptors have been detected
by means of autoradiography in the following tissues: porcine and human spinal cord (Niwa
et al. 1992), rat cerebellum (Jones et al. 1991), human airway parasympathetic ganglia
(McKay et al. 1991), guinea-pig ileum myenteric plexus (Yoshimura et al. 1996), and
human colonic nerve bundles (Inagaki et al. 1991).
2.4.3. Signal transduction mechanisms activated by endothelins in smooth muscle,
endothelium, nerves, and mitogenesis
Functionally, both types of ET receptors are capable of coupling to various GTP-binding
proteins (Gq, Gs, Gi, G0), suggesting that the down-stream signal transduction may differ
depending on the type of GTP-binding proteins involved (Takigawa et al. 1995). ET binds
to a specific receptor at the cell surface activating a G-protein, which in turn stimulates
phospholipase C (PLC) (Kasuya et al. 1989). In cultured vascular smooth muscle cells, this
stimulation can occur either via a pertussis toxin-sensitive (Reynolds et al. 1989) or
insensitive (Takuwa et al. 1990) G-protein. The activation of PLC leads to phosphatidyl
inositol hydrolysis and rapid formation of 1,4,5-inositol triphosphate (IP3), and sustained
accumulation of 1,2-diacylglycerol (DAG). IP3 stimulates the release of Ca
2+ from the
endoplasmic reticulum and DAG is linked to the activation of protein kinase C (PKC).
Smooth muscle and endothelium
In vascular smooth muscle, a key event in cellular signaling induced by ET-1 is a biphasic
increase in intracellular free Ca2+ concentration ([Ca2+]i). In vitro studies have demonstrated
that arterial smooth muscle cells show a rapid transient increase and a subsequent sustained
increase in [Ca2+]i after application of ET-1 (Simonson and Dunn 1990). The initial transient
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phase of the [Ca2+]i response is not dependent on the presence of external Ca
2+ and is the
result of IP3-induced mobilization of Ca
2+ from intracellular stores. In contrast, the sustained
increase of [Ca2+]i appears to be due to an influx of extracellular Ca
2+, which occurs as a
result of membrane effects caused by ET-mediated activation of ion channels, as well as to
the interactions of second messenger pathways within the cell (see Pollock et al. 1995).
In porcine pulmonary artery and vein Ca2+ release from intracellular stores, Ca2+ influx, and
Ca2+ sensitization were linked to the ETA-receptor. In contrast, the contraction-inducing
ETB2-receptor in the vein was coupled to Ca
2 + influx and Ca2+ sensitization but not to Ca2+
release (Sudjarwo et al. 1995). In rat pulmonary artery, the increase in myofilament Ca2+
sensitivity occurred only via activation of ETA-receptors (Evans et al. 1999). Both in
isolated and cultured tracheal smooth muscle of rat, ETA-receptors were linked to the release
of Ca2+ from intracellular stores and a subsequent intense elevation in [Ca2+]i, whereas
ETB2-receptor activation produced a rise in [Ca
2+]i, which appeared to be principally
attributable to the influx of extracellular Ca2 + (Henry 1993; Maxwell et al. 1998). In guinea-
pig trachea, the activation of ETA-receptors was coupled both to PLC activation and Ca
2+
influx via voltage-independent Ca2 + channels, whereas stimulation of ETB2-receptors caused
only membrane depolarization and opening of voltage-dependent Ca2+ channels (Inui et al.
1999).
The influx of extracellular Ca2+ in porcine coronary artery smooth muscle cells was first
reported to occur via dihydropyridine-sensitive Ca2+ channels (Goto et al. 1989). A later
report presented additional data suggesting that a specific pertussis toxin-sensitive G-protein
was directly linked to the dihydropyridine-sensitive Ca2+ channel (Kasuya et al. 1992).
However, also other Ca2+ channels may be involved in ET-1 mediated contractions of
vascular smooth muscle, and activation of a nonspecific cation channel has been proposed
(Van Renterghem et al. 1988). The entry of Ca2+ into the cell through this channel was
thought to induce depolarization, which then caused the secondary activation of voltage-
sensitive Ca2+ channels, thus facilitating additional Ca2+ entry. Furthermore, the effect of
ET-1 on the dihydropyridine-sensitive Ca2+ channel has been suggested to be indirect,
possibly via action of a receptor-operated Ca2+ channel (Gardner et al. 1992). It has also
been shown that the generation of IP3 results, in addition to mobilization of intracellular
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Ca2+ stores, in activation of Cl-  channels. The ensuing Cl- efflux causes membrane
depolarization and, in turn, activation of voltage-dependent Ca2+ channels, resulting in a
sustained elevation of [Ca2+]i which is indispensable for the maximal contraction produced
by ET-1 (Iijima et al. 1991). Signal transduction mechanisms involved in ET-1-induced
contraction of vascular smooth muscle are summarized in Fig. 2.7.
Figure 2.7. Signal transduction mechanisms involved in ET-1-induced short-term (e.g. contraction
of vascular smooth muscle) and long-term (e.g. mitogenesis) modulation of cell function. Ca2+i =
endoplasmic calcium, [Ca2+i] = intracellular free calcium concentration, CaM = calmodulin, G = G-
protein, IP3 = inositoltriphosphate, IP4 = 1,3,4,5-inositoltetrakisphosphate, MLC(K) = myosin light
chain (kinase), PIP2 = phosphatidylinositol diphosphate, PC = phosphatidylcholine, PA =
phosphatidic acid, PLC = phospholipase C, PLD = phospholipase D, PLA2 = phospholipase A2,
PGI2 = prostaglandin I2, PGE2 = prostaglandin E2, TXA2 = thromboxane A2, DAG = diacylglycerol,
PKC =protein kinase C (Rubanyi and Polokoff 1994, with permission).
ET-1-induced vasodilatation via activation of endothelial ETB1-receptors has been shown to
occur via a pertussis toxin-sensitive G-protein and an increase in IP3 production and the
cytosolic Ca2+ concentration (Emori et al. 1990). This results in subsequent synthesis and
release of NO which in turn leads to relaxation of the underlying vascular smooth muscle.
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The above-mentioned view that Ca2+ influx occurs secondary to membrane depolarization is
generally accepted with regard to ET-1 induced activation of the ETA-receptor in smooth
muscle. However, calcium signaling in other cell types appears to be quite different. It is
generally accepted that ET-1 and other agonists induce hyperpolarization of the endothelial
cell membrane thus permitting Ca2+ entry (Pollock et al. 1995). In the endothelium of rat
brain vessels, ET-1-induced Ca2+ influx was found to occur via a receptor-operated but not
via a dihydropyridine-sensitive Ca2+ channel (Stanimirovic et al. 1994). In rat aorta, the
ETB-receptor agonist IRL 1620 increased endothelial [Ca
2+]i by releasing Ca
2+ from storage
sites and by opening non-L-type Ca2+ channels (Karaki et al. 1993).
In addition to the increase in [Ca2+]i, activation of phospholipase A2  in cultured human
vascular smooth muscle cells (Resink et al. 1990) and arachidonic acid metabolism as well
as activation of phospholipase D in rat aorta (Liu et al. 1992) have been demonstrated. The
activation of phospholipase D appears to contribute to sustained DAG accumulation, which
may lead to prolonged activation of PKC (Griendling et al. 1989). In vascular smooth
muscle cells and cardiac myocytes, a change in intracellular pH (alkalinization) was induced
via stimulation of Na+-H+ exchange, which seems to be a consequence of PKC activation
(Longchampt et al. 1991). In brain capillary endothelial cells, however, the ETB1-receptor
has been reported to be coupled to Na+-H+ exchange via a PKC-independent mechanism
(Vigne et al. 1991). Furthermore, type-specific coupling may vary according to the type of
cell involved. In transfected Chinese hamster ovary (CHO) cells ETA-receptor activation
produced an increase in cAMP accumulation, whereas activation of the ETB-receptor had
the opposite effect (Aramori and Nakanishi 1992). Since both of these receptors also
stimulated phosphatidylinositol hydrolysis and arachidonic acid release, these results were
considered to indicate that the two receptors have both common and distinct signal
transduction pathways mediated through different G proteins. In addition, ET-1 and ET-3
appear to induce cGMP signaling via ETB-receptors in a variety of cells, such as porcine
kidney epithelial cells (Ishii et al. 1991), cultured bovine endothelial cells (Hirata et al.
1993), endothelial cells in rat aorta (Fujitani et al. 1993; Moritoki et al. 1993), and intact rat
glomeruli (Edwards et al. 1992).
31
The nervous system
In most instances, PLC activation in the nervous system is pertussis toxin-insensitive,
indicative of the involvement of Gq-protein. A biphasic increase in the cytosolic Ca
2+
concentration has been observed in several cells including both neurons and glial cells (see
Kuwaki et al. 1997). In rat isolated anterior pituitary (Domae et al. 1994) and dog heart
sympathetic neurons (Kushiku et al. 1991) ET-1 induced release of prostaglandin E2 and
thromboxane A2, respectively. In cultured astrocytes or astrocytoma cells, ET-receptors
(probably of the ETB-type) have been shown to be coupled to stimulation of inositol lipid
turnover and increase in [Ca2 +]i (MacCumber et al. 1990; Marsault et al. 1990; Marin et al.
1991), activation of phospholipase D (Servitja et al. 1998) and phospholipase A2 (Tencé et
al. 1992), reduction of cAMP levels (Marin et al. 1991), and expression of c-fos and a nerve
growth factor (Ladenheim et al. 1993). The production of cGMP upon stimulation by ET-1
has been demonstrated in neuroblastoma/glioma hybrid cells (Reiser 1990) and rat
cerebellar slices (Shraga-Levine et al. 1994). Immortalized Schwann cells expressed
receptors for ET-peptides (predominantly ETB-receptors) which were coupled to the
stimulation of phospholipase C and inhibition of adenylyl cyclase (Wilkins et al. 1997). In
summary, the signaling pathways involved in the actions of ET-1 in the nervous system are
similar to those seen in smooth muscle cells.
Mitogenesis
ETs are potent mitogens in cultured vascular smooth muscle cells (Chua et al. 1992) and
primary cerebellar astroglia (MacCumber et al. 1990). This action of ETs is thought to be
mediated by mitogen-activated protein (MAP) kinase cascades that induce expression of
immediate-early genes (c-fos, c-jun and c-myc) (Fig. 2.7.; see Simonson 1993). In CHO
cells c-fos gene expression was differentially regulated by human ETA- and ETB-receptors,
which responded to ET-1 at nanomolar and picomolar concentrations, respectively (Tabuchi
et al. 1994). In transfected CHO cells ETs (ET-1, ET-3 and sarafotoxin S6c (S6c))
stimulated MAP kinase cascades through human ETA- and ETB-receptor, and activation of
both receptors contributed to cell proliferation induced by ETs (Wang et al. 1994b), whereas
in rat glomerular mesangial cells ET-1 and ET-3 were also able to stimulate MAP kinases
but acted exclusively through the ETA-receptor (Wang et al. 1994a). In rat primary cultured
astrocytes, ET-1 activated MAP kinase via ETB-receptors through two independent
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signaling pathways, i.e. a PKC-dependent pathway and a pertussis toxin-sensitive G-
protein-mediated pathway (Kasuya et al. 1994).
2.5. Effects of endothelins on smooth muscle in various organ systems
2.5.1. Blood vessels
ET-1 is one of the most potent endogenous constrictors of isolated blood vessels. The
contractions, which are slowly developing and long-lasting, are initiated by the binding of
ET isopeptides to ETA-receptors on vascular smooth muscle. The involvement of ETA-
receptors has been evidenced by the order of potency of the various ET isoforms (Masaki et
al. 1994; Davenport and Masaki 1998), demonstration of the presence of these receptors in
blood vessels (Arai et al. 1990), and the ability of selective ETA-receptor antagonists (e.g.
BQ-123 or FR-139317) to inhibit the contractions (Ihara et al. 1992; Webb et al. 1992;
Cardell et al. 1993). However, in some vascular beds, activation of ETB2-receptors has also
been shown to cause vasoconstriction both in vitro and in vivo. For example, in rabbit
saphenous vein (Moreland et al. 1992) and pulmonary artery (Warner et al. 1993a), and rat
renal vasculature (Clozel et al. 1992; Pollock and Opgenorth 1993) ETB2-receptors were
involved in the contractions induced by ETs. Cocks et al. (1989) demonstrated that canine
coronary, mesenteric, femoral, renal, and internal mammary veins are 5 to 10 times more
sensitive to ET-1 than the corresponding arteries. In addition to direct vasoconstrictor
effects, ETs were able to potentiate, at threshold and subthreshold concentrations,
contractile responses to other vasoconstrictor substances, such as noradrenaline (Tabuchi et
al. 1989b) and 5-hydroxytryptamine (5-HT) (Yang et al. 1990).
In rats, intravenous injection of ET-1 initially caused a rapid and transient decrease in blood
pressure which was followed by a marked and long-lasting increase in pressure
(Yanagisawa et al. 1988a; Inoue et al. 1989). The pressor response was predominantly due
to activation of ETA-receptors on vascular smooth muscle. The depressor effect has been
proposed to be due to activation of ETB1-receptors located on the vascular endothelium,
leading to formation and release of prostaglandin I2 (de Nucci et al. 1988; Thiemermann et
33
al. 1989) and/or NO (Botting and Vane 1990). ET-1 and ET-3 have been shown to stimulate
the release of NO from isolated perfused rat and rabbit arteries (Warner et al. 1989) as well
as from intact (Warner et al. 1992c) and cultured (Hirata et al. 1993) bovine aortic
endothelial cells. ET-1 and ET-3 induced relaxation of porcine pulmonary artery strips
which was inhibited by endothelium removal, methylene blue, or L-NNA (Namiki et al.
1992). In rat aorta the ETB-receptor agonist IRL 1620 induced relaxation, the effect being
endothelium-dependent and inhibited by NG-monomethyl-L-arginine (L-NMMA) (Karaki et
al. 1993). ET-1 and ET-3 were able to induce release of prostaglandin I2 from perfused rat
mesenteric arteries (Rakugi et al. 1989) and cultured endothelial cells of bovine aorta (Filep
et al. 1991) and human umbilical vein (Kato et al. 1992). In vivo ET-1 has been shown to
induce release of prostaglandin I2 from canine (Herman et al. 1989) and rabbit endothelial
cells (Thiemermann et al. 1989).
2.5.2. Airways
ET-1 is a potent constrictor of tracheal and bronchial smooth muscle isolated from mouse,
rat, guinea-pig, rabbit, sheep and man (Uchida et al. 1988; Maggi et al. 1989a; 1989c;
Advenier et al. 1990; Henry et al. 1990; 1996). Since ET-1 was a more potent constrictor
than ET-3 (Advenier et al. 1990), the response was thought to be mediated by the ETA-
receptor. Later it was found that, in addition to ETA-receptors, ETB2-receptors also mediate
contraction in rat (Henry 1993) and mouse (Henry and Goldie 1995) trachea. In guinea-pig
(Hay 1992) and human (Hay et al. 1998) bronchus, the ET-1-induced contraction is
predominantly mediated via the activation of ETB2-receptors. In human bronchial smooth
muscle, binding experiments have revealed the presence of ETA- and ETB2-receptors in a
ratio of approximately 40:60 (Hay et al. 1998).
Removal of the epithelium has been shown to potentiate the contractile effect of ET-1 in
guinea-pig airways (Maggi et al. 1989c), suggesting that the airway epithelium suppresses
the direct smooth muscle activation induced by ET-1. In isolated rabbit trachea, low
concentrations of ET-1 caused a relaxation that could be attenuated by indomethacin or
removal of the epithelium (Grunstein et al. 1991), indicating that smooth muscle relaxant
prostanoids may mediate, at least in part, the relaxation. ET-1 and ET-3 have been shown to
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release of prostaglandin I2 from perfused rat lung via ETA-receptors (D'Orleans-Juste et al.
1992). In addition to prostaglandins, the involvement of NO has been proposed. In the
isolated guinea-pig trachea, the activation of ETA-receptors by ET-1 induced a contraction
as well as an epithelium-dependent relaxation that was mediated by NO (Emanueli et al.
1998). Also in isolated human bronchi, ET-1 exerted opposite effects on smooth muscle
tone: a direct contraction via ETB2-receptor activation and an indirect relaxation via ETA-
receptor activation and the subsequent release of NO from the epithelium (Naline et al.
1999). Furthermore, in the guinea-pig, endogenous NO has been shown to modulate ET-1-
induced bronchoconstriction by limiting the peptide’s ability to induce the release of
thromboxane A2 from smooth muscle cells, this effect possibly being mediated via ETB-
receptors (Lewis et al. 1999).
2.5.3. Gastrointestinal tract
ET-1 is a potent constrictor of the isolated perfused rat stomach (Wallace et al. 1989; Peskar
et al. 1992). It produced a phasic contraction in the longitudinal muscle from the rat gastric
body, whereas in the circular muscle the response was sustained. The contraction was
mediated by ETB2-receptors, and in the longitudinal muscle prostaglandin E2  was involved
(Shimomura et al. 1994). Furthermore, the contraction of the longitudinal smooth muscle
was dependent on Ca2+ influx through dihydropyridine-sensitive channels (Fulginiti et al.
1993). In the same study, ET-1 produced a potent concentration-dependent inhibition of the
spontaneous phasic activity as well as of carbachol-stimulated activity of the circular
smooth muscle. These inhibitory responses to ET-1 were abolished by blockade of Ca2+-
activated K+ channels by either apamin or charybdotoxin. Allcock et al. (1995)
demonstrated that, in addition to the ETB2-receptor mediated contraction, ET-1 induced a
transient relaxation in the isolated rat stomach strip which contained both longitudinal and
circular muscle. The relaxation was antagonized by the selective ETA-receptor antagonist,
BQ-123, but prolonged by the selective ETB-receptor antagonist BQ-788, and was therefore
ETA-receptor mediated.
In the isolated guinea-pig ileum, ET-1 has been shown to induce a biphasic response, i.e. an
initial transient relaxation followed by a sustained contraction (Lin and Lee 1990; 1992;
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Miasiro and Paiva 1990a). The contraction has been suggested to be mediated via the
activation of both ETA- (Lin and Lee 1992; Hori et al. 1994; Miasiro et al. 1995; Shan et al.
1996) and ETB2-receptors (Yoshinaga et al. 1992; Miasiro et al. 1995). The contractile effect
of ET-1 was reduced by indomethacin, and abolished by cromakalim or nicardipine,
indicating involvement of prostanoids, ATP-sensitive K+ channels, and dihydropyridine-
sensitive Ca2+ channels (Guimaraes and Rae 1992). In addition, in the guinea-pig ileum, the
effect of ET-1 and ET-3 seemed to be dependent on Na+ since a decrease in the Na+
gradient, either by lowering the Na+ concentration in the medium or by treating the tissue
with ouabain, reduced or abolished the contractile response to these peptides (Miasiro and
Paiva 1990a; 1992). Also the initial relaxation is thought to be mediated by both ETA- (Shan
et al. 1996) and ETB-receptors (Lin and Lee 1992; Hori et al. 1994; Miasiro et al. 1995;
Shan et al. 1996). The relaxation induced by ET-1 was abolished by apamin, pointing to the
involvement of low conductance Ca2+-activated K+ channels (Lin and Lee 1992; Shan et al.
1996), whereas pretreatment with tetrodotoxin, NOS-inhibitors, haemoglobin, or methylene
blue had no effect on the relaxation (Miasiro and Paiva 1990a; Lin and Lee 1992; Shan et al.
1996). The above-mentioned data suggest that in the guinea-pig ileum both ETA- and ETB-
receptors are present, and both may mediate contractions and relaxations. Receptor binding
experiments indicate that in the guinea-pig ileum ETB-receptors account for 90 % of the
[125I]ET-1 binding sites with the remaining 10 % consisting of ETA-receptors (Shan et al.
1996).
ET-1 has been shown to contract the isolated rat colon in a dose-dependent manner, this
effect being partly inhibited by indomethacin or piroxicam (Moummi et al. 1992). In the
guinea-pig caecum both ETA- and ETB-receptors are expressed, and ET-1 induces a
contraction that is dependent on both intracellular and extracellular Ca2+ and inhibited by
the selective ETA-receptor antagonist, BQ-123 (Okabe et al. 1995a; 1995b). In the rabbit
rectosigmoid preparation, ET-1 induced a dose-dependent biphasic contraction. The initial
transient contraction was inhibited by preincubation with an antiserum to Gi3a and the
sustained phase by preincubation with an antiserum to Gi1-2 a as well as by incubation in
Ca2+ free medium (Bitar et al. 1992). In guinea-pig taenia coli, ET-1 elicited relaxation
(Wiklund et al. 1989b; Bolger et al. 1990), suppressed spontaneous contractions and
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induced hyperpolarization that was, at least in part, due to activation of apamin-sensitive
Ca2+-activated K+ channels (Usune et al. 1991).
2.5.4. Lower urinary tract
ET-1 has been shown to induce contraction of isolated human (Maggi et al. 1989a; 1989b;
1990; Saenz de Tejada et al. 1992), pig (Persson et al. 1992), rat (Secrest and Cohen 1989;
Wiklund et al. 1989b), dog (Langenstroer et al. 1997) and rabbit (Secrest and Cohen 1989;
Garcia-Pascual et al. 1990; Saenz de Tejada et al. 1992) urinary bladder. In guinea-pig
urinary bladder, ET-1 had no effect in concentrations up to 30 nM (Wiklund et al. 1989b).
Garcia-Pascual et al. (1990) showed that, in the isolated rabbit detrusor muscle, ET-1 caused
a concentration-dependent, slowly developing contraction that was difficult to wash out. In
addition, there was a marked tachyphylaxis to the effects of the peptide. The ET-1-induced
contractions were not significantly affected by scopolamine or indomethacin, but incubation
in a Ca2+ free solution abolished them, and nifedipine had a marked inhibitory action. These
results were confirmed by Saenz de Tejada et al. (1992). On the other hand, in the human
detrusor, the ET-1-induced contractions were resistant to Ca2+ channel blockade by
nifedipine (Maggi et al. 1989b), revealing the existence of species variation in the activation
mechanisms. ET-1 stimulated phosphoinositide hydrolysis in the pig detrusor (Persson et al.
1992) as well as in the rabbit detrusor and urethral (Garcia-Pascual et al. 1993) smooth
muscle. The formation of inositol phosphates was dependent on extracellular Ca2+, and the
Ca2+ entry pathway was Ni2+-sensitive but nifedipine-resistant.
In human (Maggi et al. 1990) and rabbit (Traish et al. 1992) isolated urinary bladder, ET-3
has been shown to be a less potent contractile agent than ET-1, which suggests that ETA-
receptors predominantly mediate the response. However, competition binding analysis has
revealed two populations of receptors in the rabbit bladder: one with high affinity for ET-1
and ET-2 and low affinity for ET-3, and another with high affinity for ET-1, ET-2 and ET-3
(Traish et al. 1992). In rat bladder, the contractions were mediated by ETA-receptors since
the ETB-receptor agonists ET-3 and S6c were inactive (Donoso et al. 1994).
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In the lower urinary tract of the rabbit [125I]ET-1 binding sites have mainly been found in
the blood vessels, the outer longitudinal muscle layer, and the submucosa of the bladder and
urethra (Garcia-Pascual et al. 1990). The highest density of binding sites was found in the
vessels and the outer muscle layer. Latifpour et al. (1995) demonstrated the presence of both
ETA- and ETB-receptors in the rabbit urinary tract. The proportions of high affinity binding
sites representing ETB-receptors were 17-28 % in the bladder dome and base and 43-46 % in
the urethra. The proportions of high affinity binding sites representing ETA-receptors in
bladder dome, base and urethra ranged between 60-84%. In the ureters, only a single
receptor type (ETA) was found. In the canine bladder ET-1-like immunoreactivity was
present in the transitional epithelium (Langenstroer et al. 1997), and in the human and rabbit
bladder ET-1 activity was detected in the transitional epithelium, serosal mesothelium,
vascular endothelium, smooth muscle of the detrusor and vessels, and fibroblasts (Saenz de
Tejada et al. 1992). In the human and rabbit bladder, transcripts of ET-1 mRNA were
localized to the same structures as the ET-1-like immunoreactivity (Saenz de Tejada et al.
1992). Thus, ET-1 might act as an autocrine hormone in the regulation of the bladder wall
structure and smooth muscle tone.
2.5.5. Male reproductive tract
ET-1 has been shown to induce characteristic slowly developing, long-lasting contractions
in isolated preparations of human corpus cavernosum (Holmquist et al. 1990a; 1992; Saenz
de Tejada et al. 1991; Christ et al. 1995) and penile circumflex veins (Holmquist et al.
1992a), rabbit corpus cavernosum (Holmquist et al. 1990a; 1992a), human (Langenstroer et
al. 1993; Kobayashi et al. 1994a; Webb et al. 1995) and canine (Langenstroer et al. 1997)
prostate, and rat (Wiklund et al. 1990; 1991; Donoso et al. 1992; Eglezos et al. 1993) and
guinea-pig (Wiklund et al. 1990) vas deferens. The ET-receptors responsible for the
contraction have been shown to be either of the ETA- (Langenstroer et al. 1997) or the ETB2-
type (Webb et al. 1995) or of both the ETA- and the ETB2-type (Saenz de Tejada et al. 1991;
Kobayashi et al. 1994a; Christ et al. 1995).
In the rabbit (Holmquist et al. 1990a) and human (Christ et al. 1995) corpus cavernosum,
pretreatment with ET-1 has been shown to enhance contractions induced by noradrenaline
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or phenylephrine. In both human and rabbit tissue, VIP or muscarinic receptor stimulation
with carbachol effectively converted the ET-1-induced contraction into a relaxation
(Holmquist et al. 1990a). Likewise, in human cavernous tissue, contractions induced by ET-
1 were reversed by EFS, acetylcholine, or sodium nitroprusside (Saenz de Tejada et al.
1991). In human and rabbit corpus cavernosum, the contractions induced by ET-1 were
attenuated by nimodipine (Holmquist et al. 1990a), whereas in human circumflex veins the
effect of the peptide was independent of influx of Ca2 + through dihydropyridine-sensitive
Ca2+ channels (Holmquist et al. 1992a). On the other hand, in Ca2+ free medium, the
contractions induced by ET-1 in both corpus cavernosum and circumflex veins were greatly
reduced, but not abolished. In rabbit corpus cavernosum, the PKC inhibitor H7 abolished the
contractile component observed in Ca2+ free medium (Holmquist et al. 1990a). In addition,
ET-1 was shown to induce hydrolysis of phosphoinositides in a concentration-dependent
manner (Holmquist et al. 1992b). In cultured human corporal smooth muscle cells, ET-1
elicited a transient and concentration-dependent increase in cytosolic and nuclear Ca2 +
levels (Zhao and Christ 1995). The increases observed in nuclear Ca2+ levels were more
pronounced in cells from patients with organic erectile dysfunction than from patients with
normal erections.
In cultured human prostatic smooth muscle cells, stimulation of ETA- as well as of ETB2-
receptors has been shown to evoke an increase in [Ca2+]i via phospholipase C activation.
The sensitivity of this increase to pertussis toxin was different between the two receptors,
pointing to the involvement of different G-proteins (Saita et al. 1997).  In these cells, ET-1
and ET-3 have been shown to induce contractions as well as a concentration-dependent
increase in DNA synthesis. They are also able to promote cell growth (Saita et al. 1998).
The mitogenic effects of ET-1 and ET-3 were mediated through the activation of both ETA-
and ETB-receptors and they were inhibited by pretreatment with pertussis toxin.
The effects of ET-1 and ET-3 on penile erection after administration into the jugular vein
have also been studied in the pithed rat (Ari et al. 1996). The results indicate that in the
corporal vasculature ET-3 has predominantly a vasodilator effect, while ET-1 has a
vasodilator effect at lower doses and a vasoconstrictor effect at higher doses. The
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vasodilator action of the ETs appeared to be mediated by the activation of ETB1-receptors
and local release of NO, since L-NAME inhibited the vasodilator response.
ET-1 mRNA has been shown to be expressed in cultured endothelial cells from the human
corpus cavernosum. Further, significant amounts of ET-like immunoreactivity were
localized to the endothelium and the trabecular smooth muscle of the corpus cavernosum
(Saenz de Tejada et al. 1991), as well as to the glandular epithelium of the human
(Langenstroer et al. 1993) and canine (Langenstroer et al. 1997) prostate.
Binding sites for ET-1 have been demonstrated by autoradiography in human and rabbit
deep penile artery and human penile circumflex veins (Holmquist et al. 1992a), rat corpus
cavernosum (Bell et al. 1995) and human prostate (Kobayashi et al. 1994b). In the human
corpus cavernosum, binding experiments with labeled ETs revealed high-affinity, specific,
and saturable binding to corporal membranes. At least two distinct ET-receptors were
detected, one with high affinity for ET-1 and ET-2 and low affinity for ET-3, and another
less abundant receptor, with high affinity for ET-1, ET-2 and ET-3, which indicates that
both ETA- and ETB-receptors are present (Saenz de Tejada et al. 1991). In the rat corpus
cavernosum, the binding sites representing ETA-receptors have been reported to be
primarily located on the endothelium, and to a lesser extent to the trabecular corporal
smooth muscle (Bell et al. 1995), but these results have not been confirmed by others. In the
rabbit corpus cavernosum, ETA-receptor binding sites were primarily localized to the
smooth muscle cells and ETB-receptor binding sites to the endothelium lining the cavernous
spaces (Sullivan et al. 1997). In the cavernous tissue of diabetic rabbits, a significant
increase in ETB-receptor binding sites was detected (Sullivan et al. 1997), whereas in
hypercholesterolaemic rabbits the number of ETB-receptor binding sites became decreased
(Sullivan et al. 1998). In the human prostate, both ETA- and ETB-receptors have been
demonstrated (Kobayashi et al. 1994b; Webb et al. 1995), the vast majority (85 %) being of
the ETA-type (Le Brun et al. 1996).
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2.6. Endothelins and nervous structures
A role for ETs in the development and/or function of nerves is strongly suggested by the
neuronal presence of their mRNA, themselves, their receptors, and ECE, as well as by the
effects of ETs on neurons and glial cells in both the central nervous system (CNS) and the
peripheral nervous system (PNS) (Kuwaki et al. 1997). Both ET-1 and ET-3 are produced in
the CNS by vascular, neuronal and glial cells. The vascular synthesis of ETs in the CNS is
demonstrated by the finding that endothelial cells of porcine cerebral microvessels produce
ET-1 (Yoshimoto et al. 1990). Further, mRNA of ET-1 or ET-3 has been demonstrated in
cerebral and cerebellar neurons, and ECE-activity and mRNA for the ECEs were also
detected in the brain (Warner et al. 1992a; 1992b; Xu et al. 1994; Emoto and Yanagisawa
1995). Finally, neurosecretory granules exhibiting ET-like immunoreactivity have been
demonstrated in the CNS of several animal species including man (Giaid et al. 1989; 1991a;
Yoshizawa et al. 1989; 1990; Lee et al. 1990; Fuxe et al. 1991; Nakamura et al. 1993).
From an evolutionary point of view, ET-1 seems to be an old and conserved neuropeptide,
since ET-like immunoreactivity is found not only in mammals but also in the nervous
system of fish (Kasuya et al. 1991), and invertebrates such as insects and mollusks (Giaid et
al. 1991b; Kasuya et al. 1991). ET-1 is widely distributed within the mammalian CNS. It
has been detected in the cerebral cortex, corpus striatum, hippocampus, amygdaloid body,
pituitary gland, supraoptic and paraventricular nuclei of the hypothalamus, Purkinje cells in
the cerebellum, raphe nuclei, dorsal motor nucleus of the vagus nerve, and dorsal horn and
intermediolateral cell column in the spinal cord (Giaid et al. 1989; 1991a; Lee et al. 1990;
Yoshizawa et al. 1990). In the PNS, ET-1 expression or ET-1-like immunoreactivity has
been detected in human dorsal root ganglia (Giaid et al. 1989), nerve bundles and ganglion
cells of the two major plexuses in human colon (Inagaki et al. 1991), and myenteric neurons
cultured from rat small intestine (Eaker et al. 1995). ET-1 is also present in glial cells in the
CNS and the PNS (MacCumber et al. 1990; Jiang et al. 1993; Yamashita et al. 1993).
The presence of mRNAs for ETA- and ETB-receptors in the CNS has been confirmed by
Northern blot analysis and in situ hybridization techniques (Arai et al. 1990; Sakurai et al.
1990; Hori et al. 1992). ET-receptors are widely but unevenly distributed in the CNS; and
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the concentrations of ET-1 and ET-3 are high at those sites where ET receptors are
abundant. Autoradiographic and receptor binding studies have revealed that binding sites for
[125I]ET-1 and [125I]ET-3 are distributed throughout the CNS (Fuxe et al. 1989; Jones et al.
1989; Koseki et al. 1989; Nambi et al. 1990; Banasik et al. 1991; Niwa et al. 1992). In rats
and humans, ET-binding sites have been shown to be most densely distributed in the brain
stem and cerebellum (Jones et al. 1989). In the brain of the adult rat, the highest densities of
binding sites for radiolabelled ET-1, ET-2, ET-3, VIC and sarafotoxin S6b were observed in
the granular layer of the cerebellum (Davenport and Morton 1991). Some of the CNS
regions containing ET-receptors have been proposed to participate in the central control of
autonomic functions, such as cardiovascular and sensorimotor control, or to have a role in
the regulation of the neuroendocrine system (see Kuwaki et al. 1997). ET-receptors are also
expressed in non-neuronal cell types in the brain. The ETA-receptors have been localized to
vascular smooth muscle cells, and the ETB-receptors to glial cells, epithelial cells of choroid
plexus, and ependymal cells lining the ventricles of the brain (Hori et al. 1992). In
agreement, cultured astrocytes exhibited ET-binding sites (Hosli and Hosli 1991) many of
which were of the ETB-type (Hama et al. 1992).
Single cell dynamic video imaging of [Ca2+]i has revealed that rat cerebellar neurons and
glial cells respond differently to ETs (ET-1, ET-2, ET-3) and sarafotoxin S6b (Morton and
Davenport 1992). While the glial cells responded to these peptides with large dose-
dependent increases in [Ca2+]i in every field, the neuronal responses to ETs were only seen
in one of three fields examined. Furthermore, only 18 % of the neurons within such fields
responded to ETs or sarafotoxin S6b. Qualitatively the responses of the neurons to ET-1,
ET-2 and sarafotoxin S6b were similar to those seen in glia, whereas in neurons, contrary to
the glial cells, no responses to ET-3 were seen. However, the effects of S6c were not
investigated.
Earlier autoradiographic studies have revealed binding sites for ET-1 and ET-2, without
characterization of the receptor type involved, in parasympathetic ganglia within the human
airways (McKay et al. 1991), and the carotid body, nodose ganglion, and superior cervical
ganglion of the cat (Spyer et al. 1991). ET-1 binding in the rat carotid body has been shown
to be displaceable by FR139317, indicating the involvement of ETA-receptors (McQueen et
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al. 1995). ET-1 binding sites have also been demonstrated in nervous structures in human
and porcine coronary arteries (Chester et al. 1989; Power et al. 1989), porcine heart
(Davenport et al. 1989), and rat aorta (Jones et al. 1991). ET-receptors, predominantly of the
ETB-type, have been localized by binding studies and autoradiography to cholinergic and
adrenergic intramural neurons in cultures of guinea-pig tracheal smooth muscle (Takimoto
et al. 1993), parasympathetic ganglia, pulmonary and submucosal plexuses in porcine lung
(Kobayashi et al. 1993), cultured rat tracheal parasympathetic neurons (Fernandes et al.
1998), neural plexuses in human colon (Inagaki et al. 1991) and guinea-pig ileum
(Yoshimura et al. 1996) as well as to immortalized Schwann cells (Wilkins et al. 1997).
Sensory nerves and spinal motoneurons
The presence of ET-1 mRNA in dorsal root, and dorsal and ventral horn ganglia in the
human spinal cord suggests that ETs may play some role in peripheral sensory and motor
nerve functions and/or spinal cord sensory-motor reflexes (Giaid et al. 1989). In rats ET-1
has been shown to reduce sciatic as well as saphenous sensory and motor nerve conductance
probably via reduction of endoneurial blood flow (Zochodne et al. 1992). In the newborn rat
spinal cord ET-1 produced ventral root depolarization that was depressed by nicardipine or
a substance P antagonist (Yoshizawa et al. 1989). This suggests that ET-1 releases
substance P and that dihydropyridine-sensitive Ca2+ channels are involved in this process.
Furthermore, ET-1-like immunoreactivity has been localized to dot- and fibre-like nervous
structures in the dorsal horn of the porcine spinal cord. Therefore, ETs may have a
neuromodulatory function in the spinal cord (Yoshizawa et al. 1989). In the rat vas deferens
ET-1 inhibited the capsaicin-induced release of neurotransmitters via ETA-receptors
(Filippelli et al. 1999).
Sympathetic adrenergic nerves
ETs have been shown to affect EFS-induced release of noradrenaline in several tissues
(Table 2.4.). In isolated perfused rat mesenteric arteries (Nakamaru et al. 1989; Tabuchi et
al. 1989a; 1989b), and guinea-pig pulmonary artery (Wiklund et al. 1989a) ET-1 has been
shown to inhibit [3H]-noradrenaline release from sympathetic nerve terminals but to
potentiate the biological actions of noradrenaline at the postjunctional site. Also in guinea-
pig femoral artery (Wiklund et al. 1988) and isolated rat tail artery (Mutafova-Yambolieva
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and Westfall 1998), ET-1 inhibited release of tritiated or endogenous unlabeled
noradrenaline, respectively. In the perfused superior mesenteric vascular bed of the rat, ET-
1 potentiated the responses of both the arterial and venous vessels to exogenous
noradrenaline (Warner et al. 1990). These studies suggest that ET-1 may modulate
adrenergic neuroeffector mechanisms, at least in certain blood vessels, by inhibiting them
prejunctionally but by facilitating them postjunctionally. However, the effect of ET-1 was
different in the rabbit ear artery. In one study it enhanced the nerve-stimulation induced
release of [3H]-noradrenaline at a 10 nM dose and had an enhancing effect on contractions
induced by exogenous noradrenaline at a 1 nM concentration but had an inhibitory effect at
a 10 nM concentration (Wong-Dusting et al. 1989), whereas in another study at 1-10 nM
concentrations it had no effect on the contractions induced by exogenous noradrenaline
(Garcia-Villalon et al. 1997).
Table 2.4. Effect of ET-1, ET-3 or S6c on electrical field stimulation-induced noradrenaline
release. Concentrations are expressed in nM. ­ increase, ¯ decrease, ± no change.
a = BQ-788 inhibits, b = BQ-788 or BQ-123 inhibits.
ET-1
concentration    effect
ET-3
concentration  effect
S6c
concentration     effect
Tissue and reference
1-30
100-300
¯ a
±
10-100
300
± b
­
0.001-0.3
1-10
¯ a
­
rat tail artery
Mutafova-Yambolieva and
Westfall 1998
0.001-0.1 ¯
rat mesenteric artery
Nakamaru et al. 1989
0.001-0.3 ¯ Tabuchi et al. 1989a
1-10 ¯
guinea-pig pulmonary artery
Wiklund et al. 1989a
0.1-10 ¯
guinea-pig femoral artery
Wiklund et al. 1988
10 ­
rabbit ear artery
Wong-Dusting et al. 1989
1 ±
rabbit urethra
Garcia-Pascual et al. 1990
10 ¯ 10 ±
rat vas deferens
Wiklund et al. 1991
10 ±
guinea-pig vas deferens
Mutafova-Yambolieva and
Westfall 1995
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EFS-induced contractions have been shown to be enhanced by ET-1 in the veins of the rat
superior mesenteric vascular bed (Warner et al. 1990) as well as in guinea-pig pulmonary
artery (Wiklund et al. 1989b). In guinea-pig femoral artery (Wiklund et al. 1988), the EFS-
induced contractions were inhibited, and in rabbit ear artery ET-1 either inhibited (Wong-
Dusting et al. 1989) or had no effect on EFS-induced contractions (Garcia-Villalon et al.
1997). In rat mesenterial arteries, the effect of ET-1 on EFS-induced contractions was
inhibitory at low concentrations but potentiating at higher concentrations (Nakamaru et al.
1989; Tabuchi et al. 1989a). In rat tail artery, pretreatment with the ETB-receptor antagonist
BQ-788 increased EFS-induced contractions, whereas contractions induced by exogenous
noradrenaline were not modified (Garcia-Villalon et al. 1999). Therefore, an inhibitory
action of endogenous endothelin on sympathetic vasoconstriction may be present under
basal conditions. This inhibition could be mediated through the activation of prejunctional
ETB-receptors and subsequent inhibition of noradrenaline release from perivascular
sympathetic nerves.
In rat vas deferens, the EFS-induced release of [3H]noradrenaline has been shown to be
inhibited by ET-1 but not by ET-3 (Wiklund et al. 1991). Contractions to exogenous ATP
were enhanced by ET-1 or ET-3 whereas contractions to noradrenaline were not affected
(Wiklund et al. 1991; Donoso et al. 1992; Lau et al. 1995). EFS-induced contractions were
enhanced by ET-1 in rat (Wiklund et al. 1991; Donoso et al. 1992; Warner et al. 1993b; Lau
et al. 1995) and mouse (Rae and Calixto 1990) vas deferens. In guinea-pig vas deferens, ET-
1 enhanced ATP-induced contractions (Wiklund et al. 1990) and ET-3 produced a
significant facilitation of the EFS-induced release of unlabeled ATP, whereas the release of
unlabeled noradrenaline was unaffected (Mutafova-Yambolieva and Westfall 1995).
However, following pretreatment with the ETA-receptor antagonist BQ-123, the release of
noradrenaline was reduced and the ET-3-induced facilitation of ATP release was converted
to an inhibition. Desensitization of ETB-receptors by S6c antagonized, but did not reverse,
the facilitatory effect of ET-3. These results indicate that there are both facilitatory and
inhibitory prejunctional ET-receptors and that the release of the sympathetic cotransmitters
ATP and noradrenaline appear to be differentially modulated in guinea-pig vas deferens.
Similarly, in the rat tail artery, ET-1, ET-3 and S6c had both facilitatory and inhibitory
prejunctional effects on the release of endogenous unlabeled noradrenaline and ATP
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(Mutafova-Yambolieva and Westfall 1998). However, both transmitters were modulated in
parallel suggesting that in this tissue the ETs do not differentially modulate the release of
noradrenaline and ATP.
In canine paravertebral sympathetic ganglia, ET-3 has been shown to inhibit
neurotransmission at preganglionic sites via the stimulation of thromboxane A2  production
(Kushiku et al. 1995). In dogs, ETs may also act as inhibitory modulators of renal
noradrenergic neurotransmission via ETB-receptors, possibly via increased NO production
(Suzuki et al. 1992; Matsuo et al. 1997a; 1997b).
Parasympathetic nerves
The EFS -induced release of acetylcholine has been shown to be affected by ETs in the
airways (Table 2.5.). In rat trachea, after preincubation with [3H]choline, ET-1 and S6c
enhanced the EFS-induced tetrodotoxin-sensitive 3H-efflux via activation of prejunctional
ETA- and ETB-receptors (Knott et al. 1996). This is consistent with the results of
autoradiographic studies showing that ET-receptors, predominantly of the ETB-type, are
localized on cell bodies, axonal processes, and varicosities of cholinergic and adrenergic
intramural neurons, which co-existed in primary cultures of guinea-pig tracheal smooth
muscle cells (Takimoto et al. 1993). Activation of these receptors induced a tetrodotoxin-
susceptible increase in the [Ca2+]i that was followed by contraction of neighbouring smooth
muscle cells.
However, in sheep trachea the contractions induced by EFS, as well as the release of
endogenous unlabeled acetylcholine from cholinergic nerves, were inhibited by ET-1 and
S6c via activation of ETB-receptors (Henry et al. 1996). In contrast to the enhancing effects
described above in the rat and guinea-pig trachea, ET peptides have an inhibitory effect in
the ovine trachea. Currently, these discrepant results are attributed to species differences.
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Table 2.5. Effect of ET-1, ET-3 or S6c on electrical field stimulation-induced or spontaneous
acetylcholine release. Concentrations are expressed in nM. ­ increase, ¯ decrease, ± no change.
a = BQ-788 inhibits, b = BQ-788 or BQ-123 inhibits.
ET-1
concentration    effect
ET-3
concentration  effect
S6c
concentration    effect
Tissue and reference
100 ¯ a 10 ¯ a
sheep trachea
Henry et al. 1996
10 ­ 10 ­ b
rat trachea
Knott et al. 1996
30 ¯ 30 ¯
guinea-pig ileum
Wiklund et al. 1989c; 1991
100
0.1-30
­
­ a
100
0.1-30
­
­ a
Kan et al. 1994
Yoshimura et al. 1996
In isolated airway smooth muscle preparations, exogenous ETs have been shown to exert
powerful modulatory effects on cholinergic nerve-mediated contractions. ET-1, ET-3 or S6c
enhanced EFS-induced contractions in rabbit (Yoneyama et al. 1995b) and rat (Knott et al.
1996) trachea, as well as in rabbit (McKay et al. 1993) and human (Fernandes et al. 1996)
bronchus. In mouse trachea, low concentrations of ET-1, which exerted little or no direct
spasmogenic action, enhanced EFS-induced contractions. On the other hand, higher
concentrations of ET-1, i.e. concentrations which induced large sustained contractions,
suppressed the contractions induced by EFS when the maximal response was approached
(Henry and Goldie 1995). The ET-receptors involved in facilitation of cholinergic nerve-
mediated contraction are of either ETB- (Henry and Goldie 1995; Fernandes et al. 1996) or
both ETA- and ETB-type (Yoneyama et al. 1995b; Carr et al. 1996; Knott et al. 1996). In the
airways ET-1, ET-3 or S6c did not affect the contractions induced by the muscarinic
agonists acetylcholine and carbachol, indicating that the above enhancement of the EFS-
induced contractions was due to prejunctional effects (McKay et al. 1993; Henry and Goldie
1995; Yoneyama et al. 1995b; Carr et al. 1996; Henry et al. 1996; Knott et al. 1996).
ET-1 and ET-3 inhibited the EFS-induced contractions of guinea-pig ileum and
concomitantly increased the basal muscle tone (Wiklund et al. 1989c; 1991). In this
preparation there has later been shown to be a suppression of cholinergic neurotransmission
that is mediated by ETB-receptors (Guimaraes and Rae 1992; Warner et al. 1993b).
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Furthermore, ET-1 and ET-3 inhibited the EFS-induced release of [3H]acetylcholine
whereas the contractile response to exogenous acetylcholine was enhanced (see Table 2.5.)
(Wiklund et al. 1989c; 1991). These findings suggest that in guinea-pig ileum ET-1 and ET-
3 are modulators of cholinergic neuroeffector transmission via possible prejunctional
inhibitory and postjunctional facilitatory mechanisms. However, ET-1, ET-2, ET-3 and VIC
have been shown to directly evoke tetrodotoxin-sensitive release of [3H]acetylcholine from
guinea-pig ileum (Kan et al. 1994). In addition, ET-1 and ET-3 directly evoked via ETB-
receptors a tetrodotoxin-sensitive release of [3H]acetylcholine from the longitudinal muscle
myenteric plexus preparation of guinea-pig ileum (Yoshimura et al. 1996). These
contrasting results can most likely be explained by methodological differences, i.e. whether
the effect being studied was that of ETs on EFS-induced acetylcholine release or the direct
effect of ETs on spontaneous acetylcholine release.
In ion transport studies performed with rat colon, serosal addition of ET-1 was shown to
produce a transient increase in transepithelial short-circuit current. The increase was
inhibited by bumetanide, a Cl-  secretion inhibitor, and reduced by tetrodotoxin or removal
of extracellular Ca2+. It was concluded that the effect of ET-1 on epithelial Cl- secretion was
mediated in part via the enteric nerves and was dependent on extracellular Ca2+ (Moummi et
al. 1992).
In feline colonic parasympathetic ganglia, ET-1 was shown to modulate synaptic
transmission by slow membrane depolarization, membrane hyperpolarization, and
prolonged depression of fast excitatory postsynaptic potentials. It was suggested that the
blockade of orthodromic action potentials and the depression of fast excitatory postsynaptic
potentials were primarily due to the inhibition of acetylcholine release from presynaptic
terminals (Nishimura et al. 1991b). In the rabbit urinary bladder ganglion, ET-1 activated an
inward current and evoked membrane depolarization. The ionic mechanisms involved
receptor-operated Ca2+ and Cl- currents. ET-1 also caused an initial depression followed by
a long-lasting facilitation of the voltage-dependent Ca2+ current (Nishimura et al. 1991a).
In rat iris sphincter, ET-1, ET-3 and S6c were shown to enhance cholinergic contractions
evoked by EFS without affecting the postjunctional sensitivity to carbachol (Shinkai et al.
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1994; Shinkai-Goromaru et al. 1997). Both ETB- and ETA-receptors were involved in the
putative prejunctional facilitating effects.
2.7. Targeted deletion of genes encoding endothelins or their receptors
By selective deletion of the genes encoding ETs or their receptors, mice null-mutated for
ET-1 (Kurihara et al. 1994), ET-3 (Baynash et al. 1994), ETA- or ETB-receptors (Hosoda et
al. 1994; Puffenberger et al. 1994; Clouthier et al. 1998) have been generated. Also ECE-/-
mice have been developed (Yanagisawa et al. 1998). Recently, successful generation of ET-
2 knockout mice has also been reported (Warner et al. 1996; Webb et al. 1998). Studies of
these knockout mice have revealed that endogenous ETs are crucially involved in normal
embryonic development and morphogenesis, as well as in the maintenance of normal
cardiorespiratory and autonomic functions (see Kuwaki et al. 1997; Clouthier et al. 1998).
Knockout of the gene encoding either ET-1 or the ETA-receptor causes severe craniofacial
and thoracic blood vessel malformations (Kurihara et al. 1994; Clouthier et al. 1998),
whereas mice lacking the gene encoding the ET-3 or the ETB-receptor exhibit aganglionic
megacolon associated with color spotting of the coat (Hosoda et al. 1994; Puffenberger et al.
1994). The morphological abnormalities are all related to cells, tissues, and organs derived
from the neural crest. Thus, ETs and their receptors are essential for the normal
development of several neural crest derived structures. In addition, ETB-receptor deficient
rats become severely hypertensive if fed a high-sodium diet because they lack the normal
tonic inhibition of the renal epithelial sodium channel (Gariepy et al. 2000).
2.8. Tachyphylaxis induced by endothelins
Isolated smooth muscle preparations from various organs have been shown to exhibit
different propensity to develop tachyphylaxis to the effects of ETs. Wiklund et al. (1989b)
have shown that in guinea-pig pulmonary and femoral artery as well as in ileum,
tachyphylaxis to the ET-1-induced effects on nerve-mediated responses and basal tone is
marked, whereas in guinea-pig and rabbit taenia coli and rat anococcygeus muscle only
moderate tachyphylaxis was seen. In guinea-pig ileum, ET-1- and ET-3-induced
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desensitization of the contractile (Maggi et al. 1989a; Miasiro and Paiva 1990a; Guimaraes
and Rae 1992; Miasiro et al. 1995) as well as of the relaxant (Shan et al. 1996) component
of the biphasic response has been described. The tachyphylactic responses were most
probably linked to ETB-receptors since the contraction and relaxation developed
tachyphylaxis to the effects of the specific ETB-receptor agonists IRL 1620 and S6c,
respectively (Miasiro et al. 1995; Shan et al. 1996). Cross-tachyphylaxis was observed
between S6c and IRL 1620, but not with ET-1. However, tissues rendered tachyphylactic to
IRL 1620 still responded to S6c and ET-1, suggesting additional ET binding sites for these
two agonists (Miasiro et al. 1998; 1999).
Tachyphylaxis has been demonstrated also in other vascular tissues e.g. in rabbit aorta, and
cultured rat aortic smooth muscle cells, where the contractile responses and increase in
45Ca2+ efflux showed specific desensitization towards ET-1 (Miasiro and Paiva 1990b). In
rabbit saphenous vein tachyphylaxis was linked to the contraction mediated by ETB2-
receptors (Sudjarwo et al. 1994), whereas in the cultured rabbit pulmonary artery smooth
muscle cells, ETA-receptors coupled to the elevation in [Ca
2+]i exhibited homologous
desensitization (Owe-Young et al. 1999).
In the anaesthetized cat, the initial rapid short-lasting hypotensive response to intravenous
bolus injections of ET-1 or ET-3 was shown to become attenuated and turn to a pressor
response when either of the peptides was administered repeatedly (Le Monnier de Gouville
et al. 1990). Sustained exposure to ET-1 or ET-3 via intravenous infusion produced a sole
pressor response. These results suggested that ET-1 and ET-3 share a single vascular
receptor for vasodilation, which becomes refractory upon repeated or maintained exposure
to these peptides. Alternatively, this refractoriness could be due to the depletion of an
intracellular mediator(s) that is jointly used by the membrane binding sites of ET-1 and
ET-3. Moreover, the data suggest that the vasodilator activity of ETs depends on the rate of
their administration. In anaesthetized rats, intravenous injection of ET-1, ET-2, ET-3 or VIC
also evoked a tachyphylactic fall in blood pressure. In addition, cross-tachyphylaxis
between the peptides occurred (Le Monnier de Gouville and Cavero 1991). In isolated
perfused rat heart, repeated injection of S6c resulted in marked desensitization of the ETB1-
receptor-induced vasodilatation (Thompson et al. 1995).
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In the isolated rat and guinea-pig trachea, repeated cumulative dosing of ET-1 has been
shown to produce attenuation of the contractile response (Peachey and Kitchen 1991).
However, in the guinea-pig trachea, the degree of tachyphylaxis was dependent on the
initial response, i.e. a tissue that exhibited a good contractile response showed marked
tachyphylaxis whereas poor responders showed less attenuation. In single-dose studies with
guinea-pig trachea, tachyphylaxis was more prominent in the presence of indomethacin.
Furthermore, the ET-1-induced relaxation of guinea-pig trachea was tachyphylactic only
when ET-1 was administered in exceptionally high concentrations (0.5 and 1 µM) by the
repeated single-dosing technique. In rat trachea tachyphylaxis was seen to the contractile
responses induced by the selective ETB-receptor agonist S6c (Henry 1993).
In myenteric cholinergic neurons of guinea-pig, the VIC-evoked release of [3H]-
acetylcholine was not affected by desensitization to VIC, ET-1, ET-2 or ET-3, whereas the
tetrodotoxin-resistant component of the VIC-induced contraction was eliminated by
desensitization to the studied ETs (Kan et al. 1994). The ETs showed  homologous
desensitization with respect to the release of [3H]-acetylcholine as well as to the
tetrodotoxin-resistant contraction.
In the studies of Morton and Davenport (1992) glial cells in primary cultures of rat
cerebellum were examined. After stimulation with a low concentration (up to 1 nM) of ET-
1, ET-2, ET-3 or sarafotoxin S6b, subsequent responses could only be elicited by a higher
concentration of the same peptide. However, at higher concentrations (10-100 nM) of ET-1,
ET-3 or sarafotoxin S6b, the responses were non-additive and cross-desensitized, pointing
to the involvement of the ETB-receptor. In contrast, additional responses to ET-2 could be
elicited and heterologous desensitization did not occur between sarafotoxin S6b and ET-2.
This may imply that the action of ET-2 was mediated via more than one receptor although
this hypothesis has not been confirmed by others.
In cultured rat cortical astrocytes, ET-1, ET-3, S6c and IRL 1620 were shown to activate
phospholipase D through both ETA-and ETB-receptors (Servitja et al. 1998). This response
was rapidly desensitized by preincubation with ET-1 or S6c. In cells pretreated with S6c,
neither ET-3 nor S6c activated phospholipase D, but ET-1 was still able to elicit a response
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that was approximately 40% of the response seen in non-desensitized cells. This residual
response was not affected by BQ-788, but was fully inhibited by BQ-123 indicating that
predominantly ETB-receptors were desensitized.
In summary, the above-mentioned studies show that tachyphylaxis is clearly more common
and more pronounced in association with responses mediated via ETB-receptors, i.e. via
ETB1- and ETB2-receptors, as well as via glial ETB-receptors, than with responses mediated
via ETA-receptors. This tachyphylaxis associated with ETs may be related to their N-
terminal tail since the C-terminal hexapeptide ET(16-21) failed to induce desensitization in
the isolated guinea-pig ileum (Miasiro et al. 1993).
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3. AIMS OF THE STUDY
The main aim of the present study was to increase our knowledge of the usefulness of the
BRP as an investigational tool. A further aim was to characterize factors which directly
influence the tone of the BRP and that of the BPA, or indirectly affect the tone of these
tissues by influencing the function of the nerves which innervate them.
In more detail, the aims were:
1) to examine whether the inhibition of the nicotine-induced relaxation of the BRP could be
used as a method for the quantitative assessment of the ganglion-blocking activity of a
novel compound
2) to elucidate the mechanisms of the relaxation of the BRP induced by a small K+excess
3) to study by pharmacological tools the role of K+ movements in the neurogenic relaxation
of the BRP
4) to characterize the functional effects of ETA- and ETB-receptor agonists and antagonists
on the BRP and the BPA
5) to examine by autoradiography the distribution of the specific binding sites of a selective
ETB-receptor agonist in the BRP and the BPA
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4. MATERIALS AND METHODS
A more detailed description of the methods is given in the original communications.
4.1. Tissue collection and preparation (I-IV)
Samples of the BRP, the BPA and the BMA were obtained from bulls of different breeds
weighing 300-700 kg. In the pharmacological experiments characterizing the effects of the
ETs, 229 BRP strips from 163 bulls, 44 BPA strips from 39 bulls, and 24 BMA strips from
20 bulls were studied. In the studies of the nicotine-induced relaxation blocking activity and
the effects of K+ on the BRP tone, 237 strips from 79 and 232 strips from 81 bulls were
studied, respectively. Tissues from 4 bulls were used in the autoradiography experiments.
The BMA was used as a reference tissue because, in contrast to the BPA, it is not relaxed
during EFS after pretreatment with guanethidine, and is therefore probably devoid of
efferent inhibitory nerves (Klinge and Sjöstrand 1974). It further differs from the BPA in
the sense that it does not contain concentrations of acetylcholine which would be detectable
with the frog rectus abdominis muscle method (Klinge et al. 1978).
Within 10-25 min of slaughter, the specimens were placed in 2-5°C Tyrode solution of the
following composition (in mM): Na+ 149, K+ 2.7, Ca2+ 1.8, Mg2 + 0.5, Cl- 142, HCO3
- 12,
H2PO4
- 0.4, and glucose 5.6. BRP samples were dissected 10-30 cm distal to the level
where the paired muscle bundles pass the anal orifice (Fig. 2.1.). Samples of the BPA were
dissected from the area starting about 3 cm proximal to the branch supplying the corpus
spongiosum and ending about 3 cm distal to the branch supplying the corpus cavernosum
(Klinge and Sjöstrand 1974). In some experiments the rat thoracic aorta was used as a
reference tissue. Male Wistar rats weighing 350-450 g were killed by decapitation,
whereafter the aorta was removed and placed into cold Tyrode solution.
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4.2. Organ baths and recording of force (I-IV)
During handling, the tissues were kept in 2-5°C Tyrode solution. Longitudinal strips, 15-25
mm in length and 2-3 mm wide, were cut from the BRP. From the BPA helical strips of 2-3
mm width from about 20 mm long specimens, or rings of 2-3 mm width, were cut, whereas
from the BMA and rat thoracic aorta only rings of 2-3 mm width were prepared. The
preparations were suspended in 20 ml uncoated glass organ baths containing +35° C Tyrode
solution gassed with 95 % O2 - 5 % CO2. When the effect of K
+ free medium was studied,
KCl was replaced by an equiosmolar amount of NaCl. An initial resting force of 40-60 mN
for the BRP and of 15 mN for the arteries was applied. An equilibration time of 2-4 hr was
required for the BRP and 1-2 hr for the arteries. Changes in isometric force were recorded
by means of Grass FT 03 force displacement transducers coupled to a Grass model 7D
polygraph.
4.3. Electrical field stimulation and pharmacological stimulation (I-IV)
For EFS the muscle strips were suspended between parallel platinum electrodes (17 mm
long and 6 mm apart). Grass S48 stimulators were used to deliver rectangular shocks of 1
ms duration in 10 s trains at 4 min intervals. A voltage evoking maximal tetrodotoxin-
susceptible responses was used. The frequencies varied from 0.1 to 4 Hz.
The relaxations induced by EFS or drugs could only be studied in strips exhibiting sufficient
tone. The strips were precontracted with 5-HT (50 nM-68 µM), noradrenaline (25 nM-
2 µM) or guanethidine (10-30 µM) to achieve an appropriate tone. Guanethidine was also
used to unmask the inhibitory response to EFS. When the effect of the ET-receptor ligands
on the EFS-induced relaxations was studied, stimulation frequencies were used that
produced relaxations which were about 70 % of the maximum (Klinge and Sjöstrand 1974).
When the effect of a drug on the relaxation induced by nicotine (30 µM) or acetylcholine
(140 µM) was studied, the tone was raised with 5-HT, and the drug to be studied was added
to the organ bath 12-20 min prior to the nicotinic agonist. When acetylcholine was used, the
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organ bath contained scopolamine (1 µM) and physostigmine (1.1 µM) in order to unmask
and intensify the relaxations.
The addition of 2.7 mM or 4 mM K+  was referred to as a small potassium excess, the final
non-depolarizing K+  concentration being 5.4 or 6.7 mM, respectively. Since the addition of
4 mM KCl induced consistent relaxations, it was used as a standard small excess.
When the relaxant effect of the ET-receptor ligands was studied, the selective ETA-receptor
antagonist BQ-123 (1 µM) was used to block the possible contractile response. To study the
effect of drugs on the S6c-induced relaxation, the compound in question was added to the
organ bath 20-30 min prior to application of S6c.
When arterial preparations were used, their endothelial integrity or the successful removal
of the endothelium was verified by the presence or absence of the acetylcholine-induced
relaxation.
4.4. Assessment of the nicotine-induced relaxation blocking activity (I)
A standard dose of nicotine (30 µM) was used to induce relaxation of the BRP. The stability
of the relaxation was ensured by two consecutive controls before studying the effects of a
drug on this dose of nicotine. There was a 60-80 min interval between each application of
nicotine.
The blocking activities of the concentrations of a drug were expressed as % reduction in the
relaxation of the muscle strip. In order to construct a regression line, the responses of four or
five concentrations from the assumed linear part of the concentration-response curve were
studied. The IC50 values were calculated from the regression lines.
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4.5. Emulsion autoradiography (IV)
Autoradiography was performed in two separate sets of experiments with different batches
of [125I]BQ-3020. The pilot experiments were done with 20 µm tissue sections which were
exposed for 4 or 8 weeks. Due to the strong signal, the second set of experiments was done
with thinner (7 µm) sections and a shorter exposure (1, 2 or 4 weeks) in order to obtain a
higher resolution. In addition, fluorescence immunohistochemistry and counterstaining with
haematoxylin were performed to reveal neurofilaments and nuclei of cells.
Specimens of the BRP, the BPA and the BMA were frozen in liquid nitrogen. From all the
three tissues transverse, and from the BRP also longitudinal, sections were cut. Cryostat
sections were preincubated at room temperature for 15 min in buffer (50 mM Tris-HCl, pH
7.4, 100 mM NaCl, 5 mM MgCl2, 0.1 mM phenylmethylsulfonylfluoride, 1µM pepstatin,
2 µM leupeptin, 1 mM 1,10-phenanthroline, 40 µg/ml bacitracin and 0.1 % bovine serum
albumin) and then labeled with 100 pM [125I]BQ-3020 for 2 h (Kobayashi et al. 1993). After
incubation, the sections were washed, fixed, dried, and coated with LM-1 emulsion, dried
and exposed for 1, 2, 4 or 8 weeks at +4° C. Non-specific binding was assessed in adjacent
sections in the presence of 0.1 or 0.5 µM BQ-3020. In the BRP sections, the ability of
unlabelled 0.5 µM ET-3, S6c, BQ-788 or BQ-123 to compete for the binding sites with
[125I]BQ-3020 was also studied. The sections were counterstained with eosin in the pilot
experiments and with haematoxylin and eosin or haematoxylin alone in the second set of
experiments. All serial autoradiographs were from simultaneous experiments and were
developed in the same conditions.
4.6. Immunohistochemistry (IV)
Specimens of the BRP, the BPA and the BMA were frozen in liquid nitrogen. Transverse
sections (7 µm) were cut from all the three tissues. They were fixed with acetone, washed
with phosphate buffered saline and thereafter incubated in the presence of monoclonal
antiserum (13AA8) to neurofilament proteins. The immunoreactivity was made visible by
using fluorescein isothiocyanate-conjugated goat antimouse IgG. Control experiments
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included omission of the primary antiserum. All control specimens were devoid of specific
immunofluorescence.
4.7. Drugs
The following drugs or reagents were used: acetylcholine iodide, alcuronium chloride, 4-
aminopyridine, apamin, atracurium besylate, BQ-123 (cyclo-(D-Trp-D-Asp-Pro-D-Val-
Leu), BQ-788 (N-cis-2,6-dimethylpiperidinocarbonyl-L-g-methylleucyl-D-1-methoxy-
carbonyltryptophanyl-D-norleucine), BQ-3020 (Ac-[Ala11, Ala15]-endothelin-1 (6-21)),
[125I]BQ-3020 (2000 Ci/mmol), cromakalim, D-19 developer, fluorescein isothiocyanate-
conjugated goat anti-mouse IgG, gallamine triethiodide, glibenclamide, guanethidine
sulphate, endothelin-1, endothelin-3, hexamethonium hydrobromide, indomethacin, IRL
1038 [Cys 11,Cys15]endothelin-1-(11-21), isoprenaline sulphate, 5-hydroxytryptamine
creatinine sulphate (5-HT), Kodak Unifix fixer, LM-1 emulsion, methylene blue,
metocurine iodide, monoclonal antibody against neurofilaments (13AA8), nicotine
bitartrate, NG-nitro-L-arginine (L-NNA), l-noradrenaline bitartrate, ouabain, pancuronium
bromide, papaverine hydrochloride, pinacidil, physostigmine salicylate, prazosin,
propranolol hydrochloride, sarafotoxin S6c (S6c), scopolamine hydrobromide, sodium
nitroprusside, suxamethonium chloride, tetraethylammonium, tetrodotoxin, (+)-tubocurarine
chloride and vecuronium bromide.
4.8. Statistics
When the nicotine-induced relaxation blocking activity was studied (I) the parallelism of the
regression lines was tested by using the analysis of covariance.
The interaction between the control relaxations and the relaxations in the presence of 4-
aminopyridine (4-AP, II) was tested using analysis of variance for repeated measures with
the factors being frequency and treatment. Separate comparisons between EFS-induced
control relaxations and relaxations in the presence of 4-AP were performed by using a
paired t-test.
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The interaction between ET-1-induced control contractions and contractions in the presence
of BQ-123, the effect of endothelium removal in the BPA as well as the difference between
the BRP and BPA in the ET-1-induced dose-response curve (III) was tested by using
repeated measures analysis of variance.
5. RESULTS
5.1. Inhibition by neuromuscular blocking drugs of the nicotine-induced relaxation
of the bovine retractor penis muscle (I)
(+)-Tubocurarine, which had an IC50-value of 0.28 µM, was clearly the most potent
inhibitor of the relaxation induced by a standard 30 µM concentration of nicotine. When the
molar potency ratios were compared, alcuronium, vecuronium and metocurine were about
4-6 times less potent than (+)-tubocurarine and thus displayed notable ganglion-blocking
activity. Pancuronium was about 16 and atracurium about 30 times less potent than (+)-
tubocurarine reflecting much weaker although still detectable ganglion-blocking activity.
Suxamethonium was about 2000 and gallamine about 3000 times less potent that (+)-
tubocurarine indicating that these compounds were virtually devoid of ganglion-blocking
activity.
5.2. Effect of a small K+ excess on the tone of the bovine retractor penis muscle (II)
A small excess of K+, i.e. a final concentration of 5.4 mM or 6.7 mM, induced a rapid but
transient relaxation, which could only be repeated after washing. After the restoration of the
normal K+ concentration, the strips regained their reactivity to a varying extent within 5 min
and by 10 min the responsiveness was fully restored. The strips were, however, relaxed by a
small excess of K+ without washing immediately after a relaxation induced by 30 µM
nicotine.
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The relaxation elicited by a small excess of K+ was abolished by 0.1 µM ouabain. The
following treatments did not affect the relaxation: 15 min exposure to 10 µM L-NNA,
3.2 µM tetrodotoxin, 0.5 mM hexamethonium, 0.53 mM methylene blue, 10 µM apamin,
3 mM 4-AP, 26 mM tetraethylammonium (TEA), 0.73 mM Ba2+, or hypoxia.
5.3. Effects of K+ free medium on the relaxations of the bovine retractor penis
muscle induced by electrical field stimulation, nicotine or acetylcholine (II)
The relaxations elicited by EFS, 30 µM nicotine or 140 µM acetylcholine were
progressively attenuated during exposure to K+ free Tyrode solution, and they were
abolished within 4 to 5.5 h. The rapid and small contraction that sometimes preceded the
nicotinic relaxation, became more pronounced in parallel with the attenuation of the
relaxation. After replacement of the K+ free Tyrode with normal Tyrode solution, the
relaxations induced by EFS, nicotine or acetylcholine were partially restored within 1 h.
5.4. Effects of drugs affecting K+ currents on the tone of the bovine retractor penis
muscle (II)
5.4.1. Ouabain
Ouabain, which inhibits the cell membrane Na+-K+ ATPase by binding to its K+ binding
site, at a 0.1 µM concentration abolished the relaxation induced by a small K+ excess, but
did not affect the relaxation induced by nicotine. Ouabain slowly and dose-dependently
raised the tone of the strips, the threshold concentration being about 0.3 µM. At higher
concentrations (up to 80 µM was tested), ouabain contracted the muscle and counteracted,
but did not abolish, the nicotine-induced relaxation. The relaxations elicited by EFS with
1 Hz were slightly attenuated when 1 µM ouabain was present in the organ bath for 40 min.
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5.4.2. Cromakalim and pinacidil
Cromakalim, an opener of ATP-sensitive K+ channels, strongly relaxed the strips with a
threshold concentration of about 0.1 µM. After washing, spontaneously contracting strips
regained their tone within a few minutes. Also 2 µM pinacidil, an opener of the same type
of K+ channels, relaxed strips that had spontaneously developed tone. The relaxations
elicited by 0.5 µM cromakalim or 2 µM pinacidil were totally blocked by 10 µM
glibenclamide, an inhibitor of ATP-sensitive K+ channels.
5.4.3. 4-Aminopyridine, tetraethylammonium, glibenclamide and apamin
The voltage-dependent K+ channel blocker 4-AP (40 µM-3 mM) and Ca2+-activated
K+ channel blocker TEA (100 µM-26 mM) raised the tone of the strips and enhanced the
relaxations induced by EFS with 0.5-4 Hz. 4-AP (0.21 mM) caused a statistically
significant, frequency-dependent enhancement of the EFS-elicited relaxations. The
enhancement was more pronounced at low frequency stimulation. Furthermore, the
contractions elicited by EFS were enhanced by 4-AP and TEA.
The 30 µM nicotine- or 140 µM acetylcholine-induced relaxations were slightly attenuated
in the presence of 0.1 mM 4-AP and almost abolished by a 16-fold concentration of 4-AP.
Neither glibenclamide, an inhibitor of ATP-sensitive K+ channels, nor apamin, a blocker of
small conductance Ca2+-activated K+ channels, had any effect at 10 µM concentration on the
tone of the strips or the responses of the strips to EFS, or on the nicotine-induced relaxation.
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5.5. Effects of endothelin receptor ligands on the tone of the bovine retractor penis
muscle, penile artery and dorsal metatarsal artery (III, IV)
5.5.1. Effects of the ET-receptor agonists ET-1, ET-3, sarafotoxin S6c, and BQ-3020 and
the antagonists BQ-123, IRL-1038, and BQ-788
The BRP and the BPA were almost equipotently contracted by ET-1 in a concentration-
dependent manner, the EC50 values being 3.5 nM and 1.3 nM, respectively. In the BMA, the
ET-1-induced maximal response was 9±1 % (n=6) of that developed by 10 µM
noradrenaline and thus clearly smaller than the response obtained in the BRP (41±7 %;
n=10) and BPA (48±6 %; n=7). The threshold concentration was 0.1 nM in all tissues. In all
three tissues, the contraction was characterized by a slow onset and a long duration. In the
BRP and BPA, the endothelin ETA-receptor antagonist BQ-123 (1 µM) inhibited the
maximal contraction induced by ET-1 by about 50%. In these tissues a subthreshold
concentration of ET-1 (10 pM) enhanced the contractions evoked by 0.1 µM noradrenaline.
The selective endothelin ETB-receptor agonists S6c and BQ-3020 had no effect on the BRP,
the BPA or the BMA strips in low tone, whereas ET-3 contracted them in the absence of
BQ-123. The threshold concentration for this effect was 1 nM in both the BRP and BPA,
but 10-100 nM in the BMA. The contraction was blocked by 1 µM BQ-123. In 6 % of the
BRP strips precontracted with 5-HT, an additional contraction induced by S6c or BQ-3020
was seen. This rarely occurring contraction (Fig. 5.1.) was reversed by BQ-788 (1 µM) but
unaffected by prazosin (1-3 µM). S6c, ET-3 and BQ-3020 suppressed the spontaneous
activity induced by noradrenaline in the BPA.
The ETB-receptor agonists S6c, ET-3, and BQ-3020 all at 0.1 µM concentration relaxed the
5-HT precontracted and BQ-123 pretreated BRP strips, whereas ET-1 failed to relax the
preparations. The relaxations induced by ET-3 and BQ-3020 were considerably weaker and
more inconsistent than the relaxations elicited by S6c. The presence of BQ-123 was a
prerequisite for the relaxation when ET-3 was used. S6c was the only agonist that elicited a
relaxation of the noradrenaline-precontracted BPA. In the BMA rings, 0.1 µM S6c, ET-3, or
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BQ-3020 failed to induce relaxation. The effects of ET-receptor agonists on the tone of the
BRP, the BPA and the BMA are summarized in Table 5.1.
The ETB-receptor antagonists BQ-788 and IRL 1038 (up to 1 µM was tested) did not affect
the tone of the guanethidine-precontracted BRP strips. BQ-788 did not affect the basal tone
or the tone of the noradrenaline precontracted BPA or BMA rings.
Figure 5.1. The rare BQ-3020-induced additional contraction of the 5-hydroxytryptamine (5-HT)-
precontracted bovine retractor penis muscle. The contraction was unaffected by prazosin but
reversed by the ETB-receptor antagonist BQ-788. W = wash.
Table 5.1. Effects of endothelin receptor agonists on the tone of the bovine retractor penis muscle,
and  endothelium-intact penile and dorsal metatarsal artery. ­  = contraction, ¯ = relaxation, 0 = no
response.
Retractor penis
muscle
Penile artery Dorsal metatarsal
artery
ET-1 ­­­ ­­­ ­
ET-3 ¯¯ / ­ ­ ­
Sarafotoxin S6c ¯¯¯ / ­ ¯ 0
BQ-3020 ¯ / ­ 0 0
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5.5.2. Characteristics of the sarafotoxin S6c-induced relaxation
As stated above, all of the studied ETB-receptor agonists (S6c, ET-3 and BQ-3020) at
0.1 µM concentration caused weak and inconsistent relaxations of the 5-HT precontracted
BRP. However, the S6c-induced relaxations were more pronounced and occurred more
frequently than those elicited by ET-3 or BQ-3020, i.e. S6c elicited relaxations in 70 % of
the BRP strips, whereas ET-3 or BQ-3020-induced relaxations were noted in 24 % and
12 % of the strips, respectively. In the strips which exhibited the most pronounced
relaxation to S6c, the relaxation was 50-60 % of that induced by 30 µM papaverine, while in
the rest of the strips it was considerably smaller. In most preparations the S6c-induced
relaxation of the BRP exhibited considerable tachyphylaxis, i.e. only in 20% of the
preparations could the same size of relaxation be elicited two or three times. The S6c-
induced relaxations were totally inhibited by 1 µM BQ-788, by 97±3% by 3 µM IRL 1038,
by 83±7 % by 100 µM L-NNA, and by 77±12 % by 1 µM tetrodotoxin.
In the endothelium-intact BPA ring preparations, 1 µM acetylcholine consistently induced
clear and reproducible relaxations. S6c (0.1 µM) was the only ETB-receptor agonist that
induced slowly developing, inconsistent and weak relaxations in 50 % of these rings.
5.6. Effects of endothelin receptor ligands on the neurogenic responses induced by
electrical field stimulation or nicotine in the bovine retractor penis muscle (III
and IV)
The contractions induced by EFS were enhanced by subthreshold, i.e. 10 pM concentration
of ET-1. However, at even higher concentrations (up to 17 nM was tested) ET-1 was
without effect on EFS-induced neurogenic relaxations although the stimulation frequencies
(0.5 or 1 Hz) used were low enough to cause submaximal relaxations. Also the 30 µM
nicotine-induced neurogenic relaxations were unaffected by ET-1.
The ETB-receptor agonists S6c, ET-3, and BQ-3020 (1-100 nM) had no effect on the EFS-
induced submaximal relaxations of the BRP. The only effect was an occasionally present
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depression of the tone of the guanethidine-contracted preparations. This was seen already at
a 1 nM concentration of BQ-3020 or S6c. The ETB-receptor antagonists BQ-788 or
IRL 1038 (up to 1 µM was tested) did not affect the EFS-induced relaxations.
5.7. Autoradiographic localization of [125I]BQ-3020 binding sites in the the bovine
retractor penis muscle, penile artery, and dorsal metatarsal artery (IV)
The pilot study showed that in the BRP the high density specific binding sites for the
radioligand [125I]BQ-3020 were predominantly confined to nervous structures, i.e. the nerve
trunks in the connective tissue and minor branches within the smooth muscle bundles.
Specific binding sites were also clearly detectable throughout the smooth muscle although
their density was low. In the endothelium of the small arteries supplying the BRP there was
no detectable specific binding. Non-specific binding, as determined in the presence of
excess unlabeled BQ-3020, was extremely low.
In the BPA and BMA, the specific binding was almost exclusively confined to the
longitudinal nerve trunks in the adventitia and circular trunks in the middle and outer part of
the medial layer. However, in the BMA, the nerve bundles showing high-density specific
binding were thicker and less evenly distributed than in the BPA. In the endothelium of
these arteries, there was no detectable specific binding. Non-specific binding as determined
in the presence of excess unlabeled BQ-3020 was extremely low in both arteries.
The second autoradiography showed that in the BRP the silver grains were evenly
distributed over the nerve trunks and a higher magnification revealed that they were also
evenly distributed over the nuclei of the Schwann cells and the space between them. The
immunohistochemical staining of neurofilaments displayed the dense packing of axons in
the nerve trunks. In the BPA and BMA, the distribution of the grains over the nerve trunks
was similar to that in the BRP (Fig. 5.2.).
The ETB-receptor agonists S6c and ET-3 almost totally, i.e. to the same extent as BQ-3020,
displaced [125I]BQ-3020 from its binding sites, while the displacing effect of the ETB-
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receptor antagonist BQ-788 was somewhat weaker. In contrast, the ETA-receptor antagonist
BQ-123 exhibited only marginal displacing effect.
Figure 5.2. Autoradiography of A) the bovine penile artery and B) the bovine dorsal
metatarsal artery. In both figures a thin nerve branch runs from the upper left corner to the
lower right corner. Silver grains reflecting binding of [125I]BQ-3020 are visible over the
nuclei of Schwann cells (long arrows) and the space between them (arrowheads). sm =
smooth muscle.
6. DISCUSSION
6.1. The suitability of the nicotine-induced relaxation of the bovine retractor penis
muscle for the assessment of ganglion-blocking activity (I)
The quantitative assessment of the ganglion-blocking activity of drugs is today most
commonly performed by measuring the inhibition of the contraction of the cat nictitating
membrane evoked by preganglionic sympathetic stimulation. However, this method is
laborious and expensive. Therefore, this study was designed to evaluate to what extent the
cat nictitating membrane method could be replaced by a more simple in vitro method, i.e.
the BRP method, which measures the inhibition of the nicotine-induced relaxation. The
results show that the molar ganglion-blocking potency ratios of neuromuscular blocking
drugs as obtained in this study are in agreement with those obtained with other in vitro or in
vivo methods.
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6.1.1. Comparison of the results obtained with the bovine retractor penis muscle with
results obtained with the cat nictitating membrane
Decamethonium has been shown to be 116 times less potent as a ganglion-blocker than (+)-
tubocurarine as assessed with the cat nictitating membrane technique (Hoppe et al. 1955),
while the BRP yielded a ratio of about 43 (Alaranta et al. 1990). With the same method,
pancuronium was assessed to be about four times less potent than hexamethonium (Buckett
et al. 1968), whereas the BRP yielded an approximately tenfold difference as calculated
from the present and earlier results (Alaranta et al. 1990). The ganglion-blocking activity of
metocurine has been reported to be 5.0 (Durant et al. 1977) and 2.5 (Savarese 1979) times
weaker than that of (+)-tubocurarine when measured with the cat nictitating membrane
method, whereas this study gave a ratio of about 5.8. The rather weak ganglion-blocking
activity of metocurine has also been confirmed with the same method by Hughes and
Chapple (1976a; 1976b). In agreement with the results of the present study, atracurium has
been demonstrated to have low ganglion-blocking activity (Hughes and Chapple 1981).
Furthermore, according to Grob (1967), the order of ganglion-blocking potency of five
neuromuscular blocking drugs was (+)-tubocurarine > metocurine > decamethonium >
suxamethonium > gallamine, which is the same as that obtained with the BRP in the present
study.
However, the cat nictitating membrane technique has yielded at least one result which is
almost the opposite to that obtained in this study. Durant et al. (1979) found that the
ganglion-blocking activity of vecuronium was about 4.8 times weaker than that of
pancuronium, whereas in this study vecuronium was found to be 3.3 times more potent than
pancuronium. Further, in another study using the cat nictitating membrane technique, and
local intra-arterial administration of drugs instead of the conventional administration into
the femoral or jugular vein, the ganglion-blocking potency ratios of (+)-
tubocurarine/pancuronium/hexamethonium/gallamine were about 1 : 0.4 : 0.2 : 0.04
(Bowman and Webb 1972). The order of potency of the neuromuscular blocking drugs was
the same as in this study, whereas the activity of hexamethonium was weaker than that of
pancuronium, which was not the case with the BRP as judged from the present results as
well as from those obtained by Alaranta et al. (1990). When the cat nictitating membrane
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technique is used, it is unlikely that the potency ratios obtained with intra-arterial
administration differ significantly from those obtained after intravenous administration,
unless some of the drugs are extensively metabolized by plasma enzymes or bound to
plasma proteins. However, this is not known to occur in the case of the above-mentioned
drugs.
6.1.2. Comparison of the results obtained with the bovine retractor penis muscle with those
obtained with other in vitro methods
The ganglion-blocking activity of neuromuscular blocking drugs has also been evaluated by
in vitro methods. When the activity of hexamethonium, (+)-tubocurarine and pancuronium
at inhibiting the nicotine-induced contraction of the guinea-pig ileum was studied, the
approximate potency ratios were 2 : 1 : 0.6 (Buckett et al. 1968). An earlier study with the
same method showed that the potency ratio of hexamethonium to (+)-tubocurarine was
approximately 1.5 : 1 (Feldberg 1951). Birmingham and Hussain (1980) estimated the
potency of hexamethonium, alcuronium, (+)-tubocurarine, pancuronium and gallamine in
inhibiting the contraction of guinea-pig vas deferens induced by preganglionic stimulation
of the hypogastric nerve and obtained the ratios of 1.8 : 1.4 : 1.0 : 0.2 : 0.06. In these
studies, the order of potency of the neuromuscular blocking drugs was the same as that
obtained with the BRP, except that the vas deferens yielded a higher potency for alcuronium
than for (+)-tubocurarine. This is also in conflict with the order of potency obtained with the
conventional cat nictitating membrane technique (Hughes and Chapple 1976b). In addition,
the order of potency of hexamethonium and (+)-tubocurarine in all of the three above-
mentioned in vitro studies was opposite to that found in the BRP (Alaranta et al. 1990).
However, when the results obtained with the nictitating membrane are taken into
consideration (Bowman and Webb 1972), the potency ratio of hexamethonium to (+)-
tubocurarine obtained with the BRP is closest to the mean of the ratios obtained with
different methods.
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6.1.3. General evaluation of the bovine retractor penis muscle method
When the doses of (+)-tubocurarine needed to produce a 50% ganglionic blockade in the
guinea-pig ileum (Feldberg 1951) and the vas deferens (Birmingham and Hussain 1980) are
compared to those needed in the BRP, it becomes clear that the BRP is about 10 times more
sensitive than the guinea-pig ileum and about 160 times more sensitive than the vas
deferens. This sensitivity may partly be responsible for the fact that the BRP method yields
greater differences between compounds than the other in vitro techniques. In addition to
being sensitive, the BRP method seems to yield highly reproducible results, because the
activities obtained for (+)-tubocurarine in three different connections, i.e. by Klinge et al.
(1988), Alaranta et al. (1990), and in this study are almost the same. For hexamethonium the
same activity was obtained by both Klinge et al. (1988) and Alaranta et al. (1990). Further,
already a few applications of the drug to the organ bath will provide information about its
ganglion-blocking activity, provided that it is devoid of local anaesthetic activity, and a
regression line can be constructed by using only three appropriate dose levels. Thus, the
BRP method can, with some reservations, be used as a rapid screening method for ganglion-
blocking activity.
Although there is no clinical need to develop new ganglion-blocking drugs, it may
sometimes be important to exclude excessive ganglion-blocking activity in other types of
drugs, e.g. antimuscarinic, antihypertensive and neuromuscular blocking drugs, as well as in
molecules having one or more quaternary nitrogen groups. A distinct advantage of the
present method is that it is specific, in the sense that it discriminates well between
antinicotinic and antimuscarinic activity, because the nicotine-induced relaxation is
insensitive to scopolamine (Alaranta et al. 1990). Therefore, the atropine-like activity of the
neuromuscular blocking agents (Kharkevich and Shorr 1986) should not interfere with the
results. An additional advantage is that the BRP is waste material from slaughter-houses.
Thus, its use satisfies most or all ethical and economical demands, being in this sense more
favourable than the cat nictitating membrane technique.
It is obvious that an in vitro method cannot totally replace in vivo methods, because only in
vivo techniques allow simultaneous assessment of the ratio of ganglion-blocking activity to
a clinically desirable effect, such as the neuromuscular blocking activity. However, in the
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case of neuromuscular blocking drugs, a concomitant assessment of neuromuscular
blocking activity, e.g. with the rat phrenic nerve-diaphragm preparation, would greatly
increase the value of the information obtained. It is also clear that, for anatomical reasons
(Alaranta et al. 1989), the recording of postganglionic action potentials would be
considerably more difficult when using the BRP than the cat nictitating membrane method.
6.2. Relaxation of the bovine retractor penis muscle by a small K+ excess, and the
role of K+ and K+ channels in the regulation of its tone (II)
Previously it has been shown that the mechanism of the smooth muscle relaxant effect of a
small K+ excess differs in various tissues. In the rat anococcygeus muscle (Gibson and
James 1977), the circular muscle of pig duodenum (Kimura et al. 1984), the guinea-pig
trachealis (Chideckel et al. 1986), and the canine duodenal longitudinal muscle (Toda et al.
1992) the relaxation is caused by activation of inhibitory nerves, whereas activation of Na+-
K+ ATPase has been suggested to be the principal mechanism for the relaxation of the
canine cerebral (Toda 1974) and coronary (Murray and Sparks 1978) arteries, rat tail artery
(Webb and Bohr 1978), squirrel and rat femoral (Harker and Webb 1987) and human
resistance arteries (Hadoke et al. 1999).
In the present study, relaxation of the BRP induced by additional 4 mM K+ was unaffected
by a concentration of tetrodotoxin which was 50 times higher than that needed to abolish the
neurogenic relaxation (Klinge and Sjöstrand 1974). This indicates that the relaxation was
not a result of the activation of inhibitory nerves. Also the fact that the relaxation was
unaffected by hypoxia and methylene blue, clearly indicates that the mechanism of this
relaxation is different from that of the nitrergic neurogenic relaxation. Furthermore, the
resistance to L-NNA excludes also the involvement of the endothelial nitrergic pathway.
The relaxation was not mediated by K+ channels sensitive to apamin, 4-AP, TEA or Ba2 +.
However, the high sensitivity to ouabain indicates that the activation of Na+-K+ ATPase is
involved in or is responsible for the relaxation elicited by a small K+ excess. The attenuation
of the nicotine-induced relaxation by high concentrations of ouabain is probably in part due
to the smooth muscle contracting properties of ouabain. In human corpus cavernosum,
ouabain has been shown to increase the tension and to inhibit the relaxation induced by NO-
70
donors such as nitroprusside or S-nitrosoglutathione (Gupta et al. 1995). This indicates that
the activity of Na+-K+ ATPase modulates the contractility of the human corpus cavernosum
and that stimulation of Na+-K+ ATPase activity plays a role in the NO-induced relaxation of
this tissue.
K+ free solution has been shown to inhibit the endothelium-dependent relaxations to
acetylcholine in canine femoral arteries by preventing the action but not the release of the
EDRF(s) (Rubanyi and Vanhoutte 1988). In the BRP, the EFS- and nicotine-induced
relaxations were slowly abolished in K+ free solution. The mechanism of the abolition of
these neurogenic relaxations remains unknown. It is possible that the release of an inhibitory
neurotransmitter(s) is affected and/or that the lack of K+ interferes with certain
postjunctional events.
In this study, glibenclamide totally inhibited the relaxations of the BRP elicited by
cromakalim or pinacidil, whereas it did not affect the relaxations induced by EFS or
nicotinic receptor agonists. This indicates that in the BRP there are ATP-sensitive and/or
nucleotide diphosphate-dependent K+ channels (Beech et al. 1993). In human corpus
cavernosum smooth muscle cells, the presence of ATP-sensitive K+ channels has been
revealed by patch clamp studies (Lee et al. 1999). However, in the BRP, these kinds of
channels are not involved in the function of the inhibitory nerves or in the effects of the
transmitter(s) released from them. The site of action of cromakalim and pinacidil lies most
probably in the smooth muscle cell membranes similarly to that proposed for the smooth
muscle of the corpus cavernosum of rabbit and man (Holmquist et al. 1990b; 1990c). This is
also consistent with the finding that cromakalim induces relaxation of the BRP without
affecting the level of cGMP or cAMP (Gillespie and Sheng 1988). It is also unlikely that the
small conductance Ca2+-activated K+ channels sensitive to apamin play any crucial role in
the neurogenic relaxation of the BRP. This is in agreement with the results reported by
Bowman and Gillespie (1981).
TEA, 4-AP and charybdotoxin have been shown to augment the nitrergic relaxations to EFS
in the canine ileocolonic junction by enhancing the release of a NO-related substance
(De Man et al. 1993; 1994). Furthermore, 4-AP has been demonstrated to increase the EFS-
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induced NANC relaxation of the smooth muscle surrounding the female rabbit urethra
(Zygmunt et al. 1996). Since 4-AP did not affect the responses to exogenous NO,
nitroglycerine (De Man et al. 1993) or the NO donor SIN-1 (Zygmunt et al. 1996), it seems
likely that 4-AP was acting on neuronal K+ channels to enhance neurotransmission rather
than on the smooth muscle cells. In the BRP, the relaxations elicited by EFS were also
facilitated in the presence of 4-AP or TEA. These two compounds are known to act by
prolonging the action potential via inhibition of the K+ currents responsible for
repolarization, and they enhance Ca2+ entry into several types of nerve endings and in that
way increase transmitter release (e.g. Thesleff 1980). It is possible that in the BRP, neuronal
K+ channels, which are blocked by 4-AP or TEA, may modulate the synthesis or release of
NO by regulating the Ca2 + flow into the nerve endings. It seems that, with respect to the
enhancement of the EFS-induced relaxations, the site of action of 4-AP and TEA lies
exclusively at the nerve terminals. The possibility that these drugs also affect the membrane
potential of the smooth muscle cells cannot be completely excluded, but it is not understood
how their contractile effect could account for the enhancement of the neurogenic
relaxations.
The opposite effect of 4-AP and TEA on the relaxation induced by the nicotinic receptor
agonists might be explained by the other properties of these K+ channel blockers. It has been
reported that the release of noradrenaline induced by nicotine is attenuated by 4-AP as a
result of the inhibitory effects of 4-AP on the type of nicotinic receptors existing in ganglia
(Ikushima et al. 1981). TEA is known to possess ganglion-blocking properties, which have
also been demonstrated in the BRP (Alaranta et al. 1990). In the canine ileocolonic junction,
TEA almost abolished the relaxation to acetylcholine, and this blockade was thought to
result from an antagonistic effect of TEA at the nicotinic receptor on the NANC nerves
(De Man et al. 1993). Thus, in the case of nicotinic relaxations, activation of the inhibitory
nerves could be counteracted by the blocking effect of 4-AP and TEA on the nicotinic
receptors in the small ganglia present in the BRP (Alaranta et al. 1989). In addition, the
release of noradrenaline evoked by 4-AP and TEA (Kirpekar et al. 1978), which may
contribute to their ability to increase muscle tone, may exert a physiological antagonism
against the nicotinic relexations.
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6.3. Regulation by endothelin receptor ligands of the tone of the bovine retractor
penis muscle and penile artery, and pharmacological characterization of their
endothelin receptors (III and IV)
Contractile effects
ET-1 contracted the BRP and BPA already at 0.1 nM concentration. The sensitivity of these
smooth muscles, which maintain the flaccid state of the penis by continuous contraction,
was equally high as that found in the human corpus cavernosum (Holmquist et al. 1990a;
Saenz de Tejada et al. 1991) and prostate (Langenstroer et al. 1993; Kobayashi et al. 1994a),
whereas in human penile circumflex veins, the threshold concentration was significantly
lower (Holmquist et al. 1992a). In rat and rabbit, ET-1 has been shown to be 3- to 10-fold
more potent in contracting aortic than tracheal or urinary bladder smooth muscle (Secrest
and Cohen 1989). With respect to the BRP and BPA there was no statistically significant
difference between the dose-response curves obtained for vascular and non-vascular smooth
muscle. It is not clear whether this reflects the existence of species differences in smooth
muscle sensitivity to ET-1, because in other species the retractor penis has not been studied.
BQ-123 substantially reduced contractions elicited by ET-1 and ET-3 in the BRP and the
BPA. This indicates that the slowly developing and long-lasting contractions are mediated
predominantly via activation of ETA-receptors located on the smooth muscle cells. This
view is further supported by the finding that both tissues were more sensitive to ET-1 than
to ET-3, i.e. the threshold concentration for ET-3 was 10 times higher. However, BQ-123
did not totally inhibit the ET-1-induced contraction in either tissue, suggesting that the
blockade was incomplete at the used doses and/or that other receptors were involved. An
ETA-receptor which has low affinity for BQ-123 has been claimed to be present in rat vas
deferens (Eglezos et al. 1993; Satoh et al. 1998) and human saphenous vein (Maguire and
Davenport 1995). On the other hand, in isolated tissues the blockade by BQ-123 of ETA-
receptor-mediated contractions is always partial, never complete.
In the BRP, a subthreshold concentration of ET-1 enhanced EFS-induced contractions as
well as the contractions elicited by exogenous noradrenaline, which is in agreement with the
observations that ET-1 enhances the contractile activity of a1-adrenergic agonists in the
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corpus cavernosum of man and rabbit (Holmquist et al. 1990a; Christ et al. 1995). These
results support the hypothesis that ET-1 takes part in the maintenance of the flaccid state of
the penis.
In precontracted BRP strips, S6c and BQ-3020 occasionally elicited an additional
contraction that was inhibited by BQ-788, but was unaffected by prazosin (Fig. 5.1.). This is
in agreement with the concept that in the BRP there are a small number of ETB2-receptors
that mediate contraction, and that the release of noradrenaline from the excitatory nerves is
not involved in this contractile mechanism. It is likely that these receptors counteract the
S6c-induced nerve-mediated relaxation of the BRP and are thereby in part responsible for
its inconsistency. However, there are no pharmacological means to test the validity of this
hypothesis, since there are no antagonists currently available for differentiating between
ETB-receptors located on smooth muscle and nerves.
Relaxant effects
The S6c-induced relaxation of the BRP was blocked by BQ-788 and IRL 1038 as well as by
tetrodotoxin and L-NNA, which suggests that it was primarily mediated by ETB-receptors
located on nitrergic nerves. Muscarinic receptors, b-adrenoceptors, or synthesis of smooth
muscle relaxing prostanoids were not involved. The putative mechanism of the S6c-induced
relaxation resembles more the signal transduction mechanism activated after stimulation of
endothelial ETB1-receptors than that activated after stimulation of smooth muscle ETB2-
receptors.
Understanding of the mechanism by which S6c relaxed the BPA can only be based on
additional experiments. It is, however, noteworthy that S6c did not relax the BMA, and that
autoradiography did not reveal any specific endothelial binding sites for [125I]BQ-3020 in
either of these arteries. The fact that all three ETB receptor agonists studied transiently
suppressed the spontaneous activity in the BPA is interesting in view of the observation that
EFS of the inhibitory nerves abolishes the spontaneous activity in the BRP (Klinge and
Sjöstrand 1974).
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The inability of ET-1 to induce relaxation of the BRP or the BPA may be due to an
incomplete blockade of the contraction-mediating ETA-receptors by BQ-123. However, the
possibility cannot be excluded that the ET-receptor which mediated the S6c-induced
relaxations of these tissues represents the type which is activated by ET-3 and not by ET-1,
i.e. the ETC-receptor (Emori et al. 1990; Karne et al. 1993). This is supported by the
observation that only ET-3 caused a relaxation of the BRP. Further, the difficulty to elicit a
relaxation in the BPA could in part be accounted for by the fact that in this tissue the
number of nerve cell bodies is only about one tenth of the number present in the BRP
(Alaranta et al. 1989).
The effects of L-NNA suggest that under the experimental conditions used, there was a
basal release of NO from the BRP and the BPA. The same seems to occur in rabbit corpus
cavernosum (Knispel et al. 1991). This kind of basal release has been shown to reduce the
contractile effect of ET-1 in human omental arterioles (Riezebos et al. 1994). In the BRP,
which contains only a small amount of vascular endothelium with respect to the number of
smooth muscle cells, the principal source of spontaneously released NO was most likely the
nitrergic inhibitory nerves, because in this muscle the bulk of constitutive NOS is of
neuronal origin (Sheng et al. 1992). However, the removal of the endothelium from helical
strips of the BPA did not increase their sensitivity to the contractile effect of ET-1 or
noradrenaline, which may imply that these substances did not induce a significant release of
NO from endothelial cells. The same observation has been made in human omental arteries
(Vila et al. 1992). This conflicts with the theory that there is a basal secretion of NO from
the endothelium, though the reasons for the discrepancy are not clear. One explanation
could be that the affinity of ET-1 is lower for the endothelial ETB1-receptor than for the
smooth muscle ETA-receptor (Cocks et al. 1989). Another possibility could be that also in
the BPA, the basal secretion of NO took place predominantly from the inhibitory nerves and
was therefore not affected by removal of the endothelium.
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6.4. Localization of endothelin ETB-receptors in the bovine retractor penis muscle,
penile artery and dorsal metatarsal artery (IV)
The results of the autoradiography indicate that in all three bovine tissues examined there
are ETB-receptors located on nerve trunks, and also on minor nerve branches. In the case of
the BRP, this concept is supported by the results of the pharmacological experiments. Both
the autoradiography and the pharmacological experiments clearly indicate that in the BRP
there is a small number of ETB-receptors also on the smooth muscle cells.
Regarding the difference between the innervation of the BPA and that of the BMA, the
results of the autoradiography suggest that the occurrence of nervous ETB-receptors is not
linked to the type of efferent nerve. The resolution with this kind of autoradiography is,
however, not sufficiently high to reveal how the binding sites are distributed between the
neurons and the Schwann cells. Until this is resolved, the hypothesis has to be maintained
that there are ETB-receptors on axons and/or on Schwann cells. This conforms to the
observations that ETB-receptors exist on the perineurium of the human sural nerve
(Dashwood and Thomas 1997) and that in the brain there are ETB-receptors present in both
glia and neurons (Kuwaki et al. 1997). In addition, ETB-receptors have been identified on
immortalized Schwann cells (Wilkins et al. 1997or ) and human Schwannoma cells (Mayer
et al. 1999), and both ETA- and ETB-receptors on cholinergic neurons of the rat and guinea-
pig airways (Fernandes et al. 1999).
The lack of detectable specific binding sites for [125I]BQ-3020 in the endothelium of any of
the arteries studied is not surprising, because in various species there are arteries that are
devoid of, or have very low expression of endothelial ETB1-receptors (Russell et al. 1997).
6.5. Tachyphylaxis induced by endothelins (III and IV)
The results of the present study have confirmed that the relaxation of the BRP induced by
the ETB-receptor selective agonist S6c is primarily nerve-mediated and that it involves
activation of the L-arginine/NOS pathway. This study has also shown that the relaxation is
characterized by inconsistency, weakness and tachyphylaxis. The rapid tachyphylaxis
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associated with the vasorelaxation mediated by endothelial ETB1-receptors is well
established both in vivo and in vitro (Le Monnier de Gouville et al. 1990; Thompson et al.
1995), and the same applies to the ETB-receptor-mediated relaxation of the isolated guinea-
pig ileum (Guimaraes and Rae 1992; Lin and Lee 1992; Miasiro et al. 1993). It is
noteworthy that the ETB-receptor-mediated relaxation of the guinea-pig ileum has been
shown to be dose-independent in contrast to the ETA-receptor-mediated contraction (Lin and
Lee 1992).
The above-mentioned characteristics of the S6c-induced relaxation of the BRP precluded
construction of cumulative or non-cumulative dose-response curves. This is in sharp
contrast to the most consistent, dose-dependent, and non-tachyphylactic nerve-mediated
relaxation of the BRP elicited by nicotinic agonists as well as to the constant, frequency-
dependent, and non-fading relaxation evoked by EFS of the inhibitory nerves (Klinge et al.
1988). Instead, the S6c-induced relaxation greatly resembles the inconsistent and
tachyphylactic relaxation of penile smooth muscle of several species induced by VIP
(Sjöstrand et al. 1981; Bowman and Gillespie 1983).
6.6. Possible physiological significance of endothelins and endothelin receptors in
penile smooth muscle (III and IV)
The penis is kept in its flaccid state as a result of penile smooth muscle contraction. The
level of contraction is clearly dependent on noradrenaline released from adrenergic nerves,
but local factors, such as spontaneous myogenic activity and other contractile agonists (e.g.
thromboxane A2, prostaglandin F2a and neuropeptide Y) may also contribute (Lue et al.
2000). The potent direct contractile effect exerted by ET-1 via ETA-receptors on the BRP
and the BPA, as well as its ability to potentiate EFS- and noradrenaline-induced
contractions, suggest that in the bull, ET-1 could indeed provide an additional mechanism
for long-term contraction of penile smooth muscle and thereby for maintenance of the
flaccid state of the penis. Such a role for ETs has been suggested in other mammals on the
basis of their effects on corpus cavernosum from rabbit (Holmquist et al. 1990a; 1992a) and
man (Holmquist et al. 1990a; 1992a; Saenz de Tejada et al. 1991; Christ et al. 1995).
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Little is known about the physiological significance of endothelial ETB1-receptors in
erection. Ari et al. (1996) have shown that in the pithed rat intravenous administration of
ET-1 and ET-3 initially cause an increase in corporal pressure suggesting corporal
vasodilatation. The result is, however, not supported by autoradiographic studies using the
radioligand [125I]BQ-3020. Bell et al. (1995) could not detect any endothelial ETB1-receptors
in rat corpus cavernosum. Species differences could account for these discrepancies since in
the present study endothelial ETB1-receptors were not detected by autoradiography, whereas
in the rabbit corpus cavernosum they have been demonstrated with the same radioligand
(Sullivan et al. 1997).
The physiological significance of the ETB-receptors on the nerves of the three bovine tissues
studied cannot be determined without additional experiments. Although S6c under the
present experimental conditions to some extent promoted the function of the nitrergic nerves
that relax the BRP, it is unlikely that the nervous ETB-receptors play more than a
contributory role in the immediate induction of penile erection. This view is based on the
inconsistency, weakness and tachyphylaxis of the S6c-induced relaxations. It is further
supported by the absence of effects of ETB-receptor ligands on the submaximal EFS-
induced relaxations of the BRP. It is possible that the nervous ETB-receptors represent an
evolutional relic and lack any physiological significance. However, this proposal is at odds
with their density. One cannot exclude the possibility that they mediate activation of some
slower trophic reactions that are involved in the maintenance of the structural integrity of
penile nerves. This is indirectly supported by the facts that in mice targeted disruption of the
ETB-receptor gene prevents normal development of enteric ganglia in the distal colon, and
that the same occurs in human embryos in whom the ETB-receptor gene has undergone a
specific mutation (Hosoda et al. 1994; Puffenberger et al. 1994). It has been suggested that
ET-3, via the activation of ETB-receptors, can prevent the premature differentiation of
neural crest-derived precursors migrating to and within the murine fetal bowel, thus
enabling the precursor population to persist long enough to accomplish innervation of the
bowel (Wu et al. 1999). Endothelins, activating probably ETB-receptors, have been shown
to modulate the morphological differentiation of post-ganglionic sympathetic neurons
(Damon 1999). A trophic role of the nervous ETB-receptors is also indirectly supported by
the results obtained with the BMA, which indicate that the distribution of these receptors is
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not confined to nitrergic nerves. Finally, it is also known that ETB-receptors are able to
initiate various intracellular signal transduction events in cultured Schwann cells via
heterotrimeric G-proteins (Wilkins et al. 1997).
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7. CONCLUSIONS
1. Inhibition of the nicotine-induced relaxation of the BRP, with certain reservations, can
be used as an alternative, sensitive in vitro method for the assessment of the ganglion-
blocking activity of neuromuscular blocking agents e.g. relative to (+)-tubocurarine. In
addition, this preparation may be useful as a rapid screening method for the exclusion of
excess ganglion-blocking activity of other drugs or drug candidates.
2. Neuronal K+ channels, which are blocked by 4-AP or TEA, may affect the synthesis
and/or release of NO by regulating Ca2+ flow into the nerve endings. However, these
channels are not involved in the mediation of the effects of the inhibitory
neurotransmitter(s) on the smooth muscle cells.
3. K+ channels sensitive to cromakalim and pinacidil exist in the smooth muscle cells of the
BRP, but they are not likely to be involved in the nerve-mediated relaxation of this
muscle.
4. A small excess of K+ elicits a relaxation of the BRP due to the effects of K+ on smooth
muscle cells. This relaxation is at least partly mediated via the activation of Na+-K+
ATPase. The mechanism of this relaxation is entirely different from that induced by the
inhibitory nerves.
5. In the BRP and the BPA, contractions induced by ET-1 and ET-3 are mediated primarily
via ETA-receptors. The activation of ETA-receptors might constitute a part of the
mechanism which maintains the flaccid state of the penis. In the BRP, there appears to
be a small number of contraction-inducing ETB2-receptors.
6. In the BRP and the BPA, and also in the BMA, the ETB-receptors are predominantly
located on nerves. This suggests that the occurrence of nervous ETB-receptors is not
linked to the type of efferent nerve. It is likely that some of these receptors are located
on neurons although a glial location is also possible.
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7. The S6c-induced relaxation of the BRP involves the activation of ETB-receptors as well
as of the L-arginine/NOS pathway, and is primarily nerve-mediated. The relaxation is
characterized by inconsistency, weakness and tachyphylaxis.
8. The results do not support the view that neuronal ETB-receptors exert important
immediate effects on the function of the inhibitory nitrergic nerves in the BRP.
Therefore, these receptors probably only play a contributory role in the induction of
penile erection.
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